{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T09:53:28Z","timestamp":1776074008393,"version":"3.50.1"},"reference-count":289,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,11]],"date-time":"2026-04-11T00:00:00Z","timestamp":1775865600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T00:00:00Z","timestamp":1776038400000},"content-version":"vor","delay-in-days":2,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"The Science, Technology & Innovation Funding Authority (STDF) Applied Sciences","award":["46321"],"award-info":[{"award-number":["46321"]}]},{"name":"New Giza University"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Inflamm Regener"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Muscular dystrophies (MDs) are a set of neuromuscular diseases characterized by progressive muscle weakness and wasting. Their pathophysiology entails several aberrant genetic pathways including the perturbation of microRNA (miRNA) and other non-coding RNA (ncRNA) levels and functions, and the subsequent dysregulation of their downstream targets. In healthy tissue, ncRNAs exert their influence by fine-tuning physiological mechanisms. However, in dystrophic conditions, these ncRNAs become involved in modulation of pathological mechanisms. The main pathomechanism themes that involve ncRNAs and proteins in MD are myogenesis insufficiency, structural instability, destructive pathways, and signaling failure. This review attempts to delineate all the major contributory ncRNAs, particularly miRNAs, as well as their associated proteins involved in disease initiation, maintenance, and outcomes across the spectrum of MD subtypes.<\/jats:p>","DOI":"10.1186\/s41232-026-00415-7","type":"journal-article","created":{"date-parts":[[2026,4,11]],"date-time":"2026-04-11T01:36:05Z","timestamp":1775871365000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Emerging roles of microRNAs and other non-coding transcriptome in muscular dystrophies"],"prefix":"10.1186","volume":"46","author":[{"given":"Farah Gamal","family":"Abdelrehim","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zade","family":"Sadek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Salma A.","family":"Fahim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nada","family":"El-Ekiaby","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmed Ihab","family":"Abdelaziz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Injie Omar","family":"Fawzy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,4,11]]},"reference":[{"issue":"9307","key":"415_CR1","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1016\/S0140-6736(02)07815-7","volume":"359","author":"AE Emery","year":"2002","unstructured":"Emery AE. The muscular dystrophies. The Lancet. 2002;359(9307):687\u201395.","journal-title":"The Lancet"},{"key":"415_CR2","unstructured":"Emery AEH. Muscular Dystrophy: The Facts. Oxford: Oxford University Press; 2000. p. 190."},{"issue":"10","key":"415_CR3","doi-asserted-by":"publisher","first-page":"2266","DOI":"10.1016\/j.biocel.2013.05.001","volume":"45","author":"J Shin","year":"2013","unstructured":"Shin J, Tajrishi MM, Ogura Y, Kumar A. Wasting mechanisms in muscular dystrophy. Int J Biochem Cell Biol. 2013;45(10):2266\u201379.","journal-title":"Int J Biochem Cell Biol"},{"key":"415_CR4","doi-asserted-by":"crossref","unstructured":"Knowling S, Morris KV. Non-coding RNA and antisense RNA. Nature\u2019s trash or treasure? Biochimie. 2011;93(11):1922\u20137.","DOI":"10.1016\/j.biochi.2011.07.031"},{"key":"415_CR5","doi-asserted-by":"crossref","unstructured":"Mattick JS, Makunin IV. Non-coding RNA. Hum Mol Genet. 2006;15(suppl_1):R17\u201329.","DOI":"10.1093\/hmg\/ddl046"},{"key":"415_CR6","doi-asserted-by":"publisher","unstructured":"Hombach S, Kretz M. Non-coding RNAs: Classification, Biology and Functioning. In: Slaby O, Calin GA, editors. Non-coding RNAs in colorectal cancer. Cham: Springer International Publishing; 2016. pp. 3\u201317. Available from: https:\/\/doi.org\/10.1007\/978-3-319-42059-2_1. Cited 2024 June 9.","DOI":"10.1007\/978-3-319-42059-2_1"},{"issue":"10","key":"415_CR7","doi-asserted-by":"publisher","first-page":"19681","DOI":"10.3390\/ijms141019681","volume":"14","author":"D Erriquez","year":"2013","unstructured":"Erriquez D, Perini G, Ferlini A. Non-coding RNAs in muscle dystrophies. Int J Mol Sci. 2013;14(10):19681\u2013704.","journal-title":"Int J Mol Sci"},{"issue":"4","key":"415_CR8","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1002\/mus.880050405","volume":"5","author":"OM Scott","year":"1982","unstructured":"Scott OM, Hyde SA, Goddard C, Dubowitz V. Quantitation of muscle function in children: a prospective study in duchenne muscular dystrophy. Muscle Nerve. 1982;5(4):291\u2013301.","journal-title":"Muscle Nerve"},{"issue":"5","key":"415_CR9","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1212\/01.wnl.0000284605.27654.5a","volume":"71","author":"RA Peat","year":"2008","unstructured":"Peat RA, Smith JM, Compton AG, Baker NL, Pace RA, Burkin DJ, et al. Diagnosis and etiology of congenital muscular dystrophy. Neurology. 2008;71(5):312\u201321.","journal-title":"Neurology"},{"issue":"1","key":"415_CR10","volume":"2012","author":"OdelR Cruz Guzm\u00e1n","year":"2012","unstructured":"Cruz Guzm\u00e1n OdelR, Ch\u00e1vez Garc\u00eda AL, Rodr\u00edguez-Cruz M. Muscular dystrophies at different ages: metabolic and endocrine alterations. Int J Endocrinol. 2012;2012(1):485376.","journal-title":"Int J Endocrinol"},{"issue":"2","key":"415_CR11","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/j.cell.2005.05.010","volume":"122","author":"CA Collins","year":"2005","unstructured":"Collins CA, Olsen I, Zammit PS, Heslop L, Petrie A, Partridge TA, et al. Stem cell function, self-renewal, and behavioral heterogeneity of cells from the adult muscle satellite cell niche. Cell. 2005;122(2):289\u2013301.","journal-title":"Cell"},{"issue":"1","key":"415_CR12","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.ydbio.2006.02.022","volume":"294","author":"G Shefer","year":"2006","unstructured":"Shefer G, Van de Mark DP, Richardson JB, Yablonka-Reuveni Z. Satellite-cell pool size does matter: defining the myogenic potency of aging skeletal muscle. Dev Biol. 2006;294(1):50\u201366.","journal-title":"Dev Biol"},{"issue":"1","key":"415_CR13","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.scr.2014.10.007","volume":"14","author":"L Boldrin","year":"2015","unstructured":"Boldrin L, Zammit PS, Morgan JE. Satellite cells from dystrophic muscle retain regenerative capacity. Stem Cell Res. 2015;14(1):20\u20139.","journal-title":"Stem Cell Res"},{"issue":"3","key":"415_CR14","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1007\/s00441-010-0976-6","volume":"340","author":"M Kottlors","year":"2010","unstructured":"Kottlors M, Kirschner J. Elevated satellite cell number in Duchenne muscular dystrophy. Cell Tissue Res. 2010;340(3):541\u20138.","journal-title":"Cell Tissue Res"},{"key":"415_CR15","doi-asserted-by":"crossref","unstructured":"Chen JF, Tao Y, Li J, Deng Z, Yan Z, Xiao X, et al. microRNA-1 and microRNA-206 regulate skeletal muscle satellite cell proliferation and differentiation by repressing Pax7. J Cell Biol. 2010;190(5):867\u201379.","DOI":"10.1083\/jcb.200911036"},{"issue":"1","key":"415_CR16","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/1471-213X-11-34","volume":"11","author":"A Koutsoulidou","year":"2011","unstructured":"Koutsoulidou A, Mastroyiannopoulos NP, Furling D, Uney JB, Phylactou LA. Expression of miR-1, miR-133a, miR-133b and miR-206 increases during development of human skeletal muscle. BMC Dev Biol. 2011;11(1):34.","journal-title":"BMC Dev Biol"},{"issue":"24","key":"415_CR17","doi-asserted-by":"publisher","first-page":"5041","DOI":"10.1007\/s00018-019-03165-7","volume":"76","author":"D Kong","year":"2019","unstructured":"Kong D, He M, Yang L, Zhou R, Yan YQ, Liang Y, et al. MiR-17 and miR-19 cooperatively promote skeletal muscle cell differentiation. Cell Mol Life Sci. 2019;76(24):5041\u201354.","journal-title":"Cell Mol Life Sci"},{"issue":"1","key":"415_CR18","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.biocel.2017.07.020","volume":"90","author":"C Liu","year":"2017","unstructured":"Liu C, Wang M, Chen M, Zhang K, Gu L, Li Q, et al. MiR-18a induces myotubes atrophy by down-regulating IgfI. Int J Biochem Cell Biol. 2017;90(1):145\u201354.","journal-title":"Int J Biochem Cell Biol"},{"issue":"10","key":"415_CR19","doi-asserted-by":"publisher","first-page":"e0205514","DOI":"10.1371\/journal.pone.0205514","volume":"13","author":"GL Vita","year":"2018","unstructured":"Vita GL, Polito F, Oteri R, Arrigo R, Ciranni AM, Musumeci O, et al. Hippo signaling pathway is altered in Duchenne muscular dystrophy. PLoS ONE. 2018;13(10):e0205514.","journal-title":"PLoS ONE"},{"issue":"1","key":"415_CR20","doi-asserted-by":"publisher","first-page":"2482","DOI":"10.1038\/s41467-018-04892-4","volume":"9","author":"E Cerro-Herreros","year":"2018","unstructured":"Cerro-Herreros E, Sabater-Arcis M, Fernandez-Costa JM, Moreno N, Perez-Alonso M, Llamusi B, et al. miR-23b and miR-218 silencing increase Muscleblind-like expression and alleviate myotonic dystrophy phenotypes in mammalian models. Nat Commun. 2018;9(1):2482.","journal-title":"Nat Commun"},{"issue":"19","key":"415_CR21","doi-asserted-by":"publisher","first-page":"2180","DOI":"10.1101\/gad.198085.112","volume":"26","author":"BK Dey","year":"2012","unstructured":"Dey BK, Gagan J, Yan Z, Dutta A. miR-26a is required for skeletal muscle differentiation and regeneration in mice. Genes Dev. 2012;26(19):2180\u201391.","journal-title":"Genes Dev"},{"key":"415_CR22","doi-asserted-by":"crossref","unstructured":"Lozano-Velasco E, Contreras A, Crist C, Hern\u00e1ndez-Torres F, Franco D, Ar\u00e1nega AE. Pitx2c modulates Pax3+\/Pax7+ cell populations and regulates Pax3 expression by repressing miR27 expression during myogenesis. Dev Biol. 2011;357(1):165\u201378.","DOI":"10.1016\/j.ydbio.2011.06.039"},{"issue":"16","key":"415_CR23","doi-asserted-by":"publisher","first-page":"13805","DOI":"10.1074\/jbc.M110.192625","volume":"286","author":"CE Winbanks","year":"2011","unstructured":"Winbanks CE, Wang B, Beyer C, Koh P, White L, Kantharidis P, et al. TGF-\u03b2 Regulates miR-206 and miR-29 to Control Myogenic Differentiation through Regulation of HDAC4. J Biol Chem. 2011;286(16):13805\u201314.","journal-title":"J Biol Chem"},{"issue":"7","key":"415_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41419-018-0769-5","volume":"9","author":"M Cappella","year":"2018","unstructured":"Cappella M, Perfetti A, Cardinali B, Garcia-Manteiga JM, Carrara M, Provenzano C, et al. High-throughput analysis of the RNA-induced silencing complex in myotonic dystrophy type 1 patients identifies the dysregulation of miR-29c and its target ASB2. Cell Death Dis. 2018;9(7):1\u201311.","journal-title":"Cell Death Dis"},{"issue":"2","key":"415_CR25","doi-asserted-by":"publisher","first-page":"182","DOI":"10.3390\/ijms17020182","volume":"17","author":"BW Zhang","year":"2016","unstructured":"Zhang BW, Cai HF, Wei XF, Sun JJ, Lan XY, Lei CZ, et al. miR-30-5p regulates muscle differentiation and alternative splicing of muscle-related genes by targeting MBNL. Int J Mol Sci. 2016;17(2):182.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"415_CR26","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.stem.2012.03.011","volume":"11","author":"CG Crist","year":"2012","unstructured":"Crist CG, Montarras D, Buckingham M. Muscle satellite cells are primed for myogenesis but maintain quiescence with sequestration of Myf5 mRNA targeted by microRNA-31 in mRNP granules. Cell Stem Cell. 2012;11(1):118\u201326.","journal-title":"Cell Stem Cell"},{"issue":"2","key":"415_CR27","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1038\/embor.2010.208","volume":"12","author":"D Cacchiarelli","year":"2011","unstructured":"Cacchiarelli D, Incitti T, Martone J, Cesana M, Cazzella V, Santini T, et al. miR-31 modulates dystrophin expression: new implications for Duchenne muscular dystrophy therapy. EMBO Rep. 2011;12(2):136\u201341.","journal-title":"EMBO Rep"},{"key":"415_CR28","doi-asserted-by":"crossref","unstructured":"Lozano-Velasco E, Vallejo D, Esteban FJ, Doherty C, Hern\u00e1ndez-Torres F, Franco D, et al. A Pitx2-microRNA pathway modulates cell proliferation in myoblasts and skeletal-muscle satellite cells and promotes their commitment to a myogenic cell fate. Mol Cell Biol. 2015;35(17):2892\u2013909.","DOI":"10.1128\/MCB.00536-15"},{"issue":"192","key":"415_CR29","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1083\/jcb.201007165","volume":"3","author":"Y Ge","year":"2011","unstructured":"Ge Y, Yuting S, Chen J. IGF-II is regulated by microRNA-125b in skeletal myogenesis. J Cell Biol. 2011;3(192):69\u201381.","journal-title":"J Cell Biol"},{"issue":"2","key":"415_CR30","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1016\/j.cell.2011.09.028","volume":"147","author":"M Cesana","year":"2011","unstructured":"Cesana M, Cacchiarelli D, Legnini I, Santini T, Sthandier O, Chinappi M, et al. A long noncoding RNA controls muscle differentiation by functioning as a competing endogenous RNA. Cell. 2011;147(2):358\u201369.","journal-title":"Cell"},{"issue":"2","key":"415_CR31","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1038\/ng1725","volume":"38","author":"JF Chen","year":"2006","unstructured":"Chen JF, Mandel EM, Thomson JM, Wu Q, Callis TE, Hammond SM, et al. The role of microRNA-1 and microRNA-133 in skeletal muscle proliferation and differentiation. Nat Genet. 2006;38(2):228\u201333.","journal-title":"Nat Genet"},{"key":"415_CR32","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/j.bbrc.2008.11.041","volume":"9;378(2)","author":"W Kuang","year":"2009","unstructured":"Kuang W, Tan J, Duan Y, Duan J, Wang W, Jin F, et al. Cyclic stretch induced miR-146a upregulation delays C2C12 myogenic differentiation through inhibition of Numb. Biochem Biophys Res Commun. 2009;9;378(2):259\u201363.","journal-title":"Biochem Biophys Res Commun"},{"key":"415_CR33","doi-asserted-by":"crossref","unstructured":"Fiorillo AA, Heier CR, Novak JS, Tully CB, Brown KJ, Uaesoontrachoon K, et al. TNF-\u03b1-induced microRNAs control dystrophin expression in becker muscular dystrophy. Cell Rep. 2015;12(10):1678\u201390.","DOI":"10.1016\/j.celrep.2015.07.066"},{"issue":"19","key":"415_CR34","doi-asserted-by":"publisher","first-page":"9500","DOI":"10.1093\/nar\/gkv849","volume":"43","author":"E Koscianska","year":"2015","unstructured":"Koscianska E, Witkos TM, Kozlowska E, Wojciechowska M, Krzyzosiak WJ. Cooperation meets competition in microRNA-mediated DMPK transcript regulation. Nucleic Acids Res. 2015;43(19):9500\u201318.","journal-title":"Nucleic Acids Res"},{"issue":"2","key":"415_CR35","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.yexmp.2017.01.008","volume":"102","author":"L Wang","year":"2017","unstructured":"Wang L, Xi Y, Sun C, Zhang F, Jiang H, He Q, et al. CDK3 is a major target of miR-150 in cell proliferation and anti-cancer effect. Exp Mol Pathol. 2017;102(2):181\u201390.","journal-title":"Exp Mol Pathol"},{"issue":"41","key":"415_CR36","doi-asserted-by":"publisher","first-page":"35339","DOI":"10.1074\/jbc.M111.273276","volume":"286","author":"HY Seok","year":"2011","unstructured":"Seok HY, Tatsuguchi M, Callis TE, He A, Pu WT, Wang DZ. miR-155 Inhibits expression of the MEF2A protein to repress skeletal muscle differentiation *. J Biol Chem. 2011;286(41):35339\u201346.","journal-title":"J Biol Chem"},{"issue":"9","key":"415_CR37","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.1038\/cdd.2013.62","volume":"20","author":"MS Alexander","year":"2013","unstructured":"Alexander MS, Kawahara G, Motohashi N, Casar JC, Eisenberg I, Myers JA, et al. Microrna-199a is induced in dystrophic muscle and affects WNT signaling, cell proliferation, and myogenic differentiation. Cell Death Differ. 2013;20(9):1194\u2013208.","journal-title":"Cell Death Differ"},{"key":"415_CR38","doi-asserted-by":"publisher","first-page":"4814696","DOI":"10.1155\/2018\/4814696","volume":"2018","author":"M D\u2019Agostino","year":"2018","unstructured":"D\u2019Agostino M, Torcinaro A, Madaro L, Marchetti L, Sileno S, Beji S, et al. Role of miR-200c in myogenic differentiation impairment via p66Shc: implication in skeletal muscle regeneration of dystrophic mdx mice. Oxid Med Cell Longev. 2018;2018:4814696.","journal-title":"Oxid Med Cell Longev"},{"issue":"19","key":"415_CR39","first-page":"3631","volume":"128","author":"D Koutalianos","year":"2015","unstructured":"Koutalianos D, Koutsoulidou A, Mastroyiannopoulos NP, Furling D, Phylactou LA. MyoD transcription factor induces myogenesis by inhibiting Twist-1 through miR-206. J Cell Sci. 2015;128(19):3631\u201345.","journal-title":"J Cell Sci"},{"issue":"10","key":"415_CR40","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0007607","volume":"4","author":"B Cardinali","year":"2009","unstructured":"Cardinali B, Castellani L, Fasanaro P, Basso A, Alem\u00e0 S, Martelli F, et al. Microrna-221 and Microrna-222 modulate differentiation and maturation of skeletal muscle cells. PLoS ONE. 2009;4(10):e7607.","journal-title":"PLoS ONE"},{"issue":"10","key":"415_CR41","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2017.479","volume":"8","author":"G Li","year":"2017","unstructured":"Li G, Luo W, Abdalla BA, Ouyang H, Yu J, Hu F, et al. MiRNA-223 upregulated by MYOD inhibits myoblast proliferation by repressing IGF2 and facilitates myoblast differentiation by inhibiting ZEB1. Cell Death Dis. 2017;8(10):e3094\u2013e3094.","journal-title":"Cell Death Dis"},{"issue":"13","key":"415_CR42","doi-asserted-by":"publisher","first-page":"2138","DOI":"10.1091\/mbc.e10-01-0062","volume":"21","author":"S Sarkar","year":"2010","unstructured":"Sarkar S, Dey BK, Dutta A. MiR-322\/424 and -503 are induced during muscle differentiation and promote cell cycle quiescence and differentiation by down-regulation of Cdc25A. Mol Biol Cell. 2010;21(13):2138\u201349.","journal-title":"Mol Biol Cell"},{"issue":"3","key":"415_CR43","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41419-019-1432-5","volume":"10","author":"MJ Zhao","year":"2019","unstructured":"Zhao MJ, Xie J, Shu WJ, Wang HY, Bi J, Jiang W, et al. MiR-15b and miR-322 inhibit SETD3 expression to repress muscle cell differentiation. Cell Death Dis. 2019;10(3):1\u201313.","journal-title":"Cell Death Dis"},{"issue":"7","key":"415_CR44","doi-asserted-by":"publisher","first-page":"1490","DOI":"10.1016\/j.bbadis.2015.04.010","volume":"1852","author":"X Peng","year":"2015","unstructured":"Peng X, Shen X, Chen X, Liang R, Azares AR, Liu Y. Celf1 regulates cell cycle and is partially responsible for defective myoblast differentiation in myotonic dystrophy RNA toxicity. Biochim Biophys Acta BBA - Mol Basis Dis. 2015;1852(7):1490\u20137.","journal-title":"Biochim Biophys Acta BBA - Mol Basis Dis"},{"issue":"22","key":"415_CR45","doi-asserted-by":"publisher","first-page":"19431","DOI":"10.1074\/jbc.M111.219006","volume":"286","author":"J Gagan","year":"2011","unstructured":"Gagan J, Dey BK, Layer R, Yan Z, Dutta A. MicroRNA-378 targets the myogenic repressor MyoR during myoblast differentiation. J Biol Chem. 2011;286(22):19431\u20138.","journal-title":"J Biol Chem"},{"issue":"11","key":"415_CR46","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.135576","volume":"5","author":"P Podkalicka","year":"2020","unstructured":"Podkalicka P, Mucha O, Bronisz-Budzy\u0144ska I, Kozakowska M, Pietraszek-Gremplewicz K, Cetnarowska A, et al. Lack of miR-378 attenuates muscular dystrophy in mdx mice. JCI Insight. 2020;5(11):e135576.","journal-title":"JCI Insight"},{"issue":"1","key":"415_CR47","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1186\/1750-1172-8-55","volume":"8","author":"N Harafuji","year":"2013","unstructured":"Harafuji N, Schneiderat P, Walter MC, Chen YW. miR-411 is up-regulated in FSHD myoblasts and suppresses myogenic factors. Orphanet J Rare Dis. 2013;8(1):55.","journal-title":"Orphanet J Rare Dis"},{"issue":"1","key":"415_CR48","doi-asserted-by":"publisher","first-page":"7713","DOI":"10.1038\/ncomms8713","volume":"6","author":"R Wu","year":"2015","unstructured":"Wu R, Li H, Zhai L, Zou X, Meng J, Zhong R, et al. MicroRNA-431 accelerates muscle regeneration and ameliorates muscular dystrophy by targeting Pax7 in mice. Nat Commun. 2015;6(1):7713.","journal-title":"Nat Commun"},{"key":"415_CR49","doi-asserted-by":"crossref","unstructured":"Dey BK, Gagan J, Dutta A. miR-206 and -486 induce myoblast differentiation by downregulating Pax7. Mol Cell Biol. 2011. Available from: https:\/\/www.tandfonline.com\/doi\/abs\/10.1128\/MCB.01009-10. Cited 2024 May 26.","DOI":"10.1128\/MCB.01009-10"},{"issue":"1","key":"415_CR50","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1096\/fj.13-233155","volume":"28","author":"AS de la Garza-Rodea","year":"2014","unstructured":"de la Garza-Rodea AS, Baldwin DM, Oskouian B, Place RF, Bandhuvula P, Kumar A, et al. Sphingosine phosphate lyase regulates myogenic differentiation via S1P receptor-mediated effects on myogenic microRNA expression. FASEB J. 2014;28(1):506\u201319.","journal-title":"FASEB J"},{"issue":"6","key":"415_CR51","doi-asserted-by":"publisher","first-page":"2651","DOI":"10.1172\/JCI73579","volume":"124","author":"MS Alexander","year":"2014","unstructured":"Alexander MS, Casar JC, Motohashi N, Vieira NM, Eisenberg I, Marshall JL, et al. MicroRNA-486\u2013dependent modulation of DOCK3\/PTEN\/AKT signaling pathways improves muscular dystrophy\u2013associated symptoms. J Clin Invest. 2014;124(6):2651\u201367.","journal-title":"J Clin Invest"},{"issue":"3","key":"415_CR52","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1016\/j.celrep.2018.03.101","volume":"23","author":"D Dimartino","year":"2018","unstructured":"Dimartino D, Colantoni A, Ballarino M, Martone J, Mariani D, Danner J, et al. The long non-coding RNA lnc-31 interacts with Rock1 mRNA and mediates its YB-1-dependent translation. Cell Rep. 2018;23(3):733\u201340.","journal-title":"Cell Rep"},{"issue":"7","key":"415_CR53","doi-asserted-by":"publisher","first-page":"3054","DOI":"10.1096\/fj.14-259952","volume":"29","author":"X Han","year":"2015","unstructured":"Han X, Yang F, Cao H, Liang Z. Malat1 regulates serum response factor through miR-133 as a competing endogenous RNA in myogenesis. FASEB J. 2015;29(7):3054\u201364.","journal-title":"FASEB J"},{"issue":"6466","key":"415_CR54","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1126\/science.aax1694","volume":"366","author":"A de Morree","year":"2019","unstructured":"de Morree A, Klein JDD, Gan Q, Farup J, Urtasun A, Kanugovi A, et al. Alternative polyadenylation of Pax3 controls muscle stem cell fate and muscle function. Science. 2019;366(6466):734\u20138.","journal-title":"Science"},{"issue":"6","key":"415_CR55","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1016\/j.stem.2019.03.019","volume":"24","author":"AD Vartanian","year":"2019","unstructured":"Vartanian AD, Qu\u00e9tin M, Michineau S, Aurad\u00e9 F, Hayashi S, Dubois C, et al. PAX3 confers functional heterogeneity in skeletal muscle stem cell responses to environmental stress. Cell Stem Cell. 2019;24(6):958-973.e9.","journal-title":"Cell Stem Cell"},{"issue":"1","key":"415_CR56","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/s13395-015-0061-7","volume":"5","author":"A Filareto","year":"2015","unstructured":"Filareto A, Rinaldi F, Arpke RW, Darabi R, Belanto JJ, Toso EA, et al. Pax3-induced expansion enables the genetic correction of dystrophic satellite cells. Skelet Muscle. 2015;5(1):36.","journal-title":"Skelet Muscle"},{"issue":"3","key":"415_CR57","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0058405","volume":"8","author":"SL Hebert","year":"2013","unstructured":"Hebert SL, Daniel ML, McLoon LK. The role of Pitx2 in maintaining the phenotype of myogenic precursor cells in the extraocular muscles. PLoS ONE. 2013;8(3):e58405.","journal-title":"PLoS ONE"},{"issue":"6","key":"415_CR58","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1016\/j.yexcr.2011.01.018","volume":"317","author":"KM Kallestad","year":"2011","unstructured":"Kallestad KM, Hebert SL, McDonald AA, Daniel ML, Cu SR, McLoon LK. Sparing of extraocular muscle in aging and muscular dystrophies: a myogenic precursor cell hypothesis. Exp Cell Res. 2011;317(6):873\u201385.","journal-title":"Exp Cell Res"},{"issue":"43","key":"415_CR59","doi-asserted-by":"publisher","first-page":"17016","DOI":"10.1073\/pnas.0708115104","volume":"104","author":"I Eisenberg","year":"2007","unstructured":"Eisenberg I, Eran A, Nishino I, Moggio M, Lamperti C, Amato AA, et al. Distinctive patterns of microRNA expression in primary muscular disorders. Proc Natl Acad Sci U S A. 2007;104(43):17016\u201321.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"415_CR60","doi-asserted-by":"publisher","first-page":"345","DOI":"10.7150\/ijbs.10921","volume":"11","author":"G Ma","year":"2015","unstructured":"Ma G, Wang Y, Li Y, Cui L, Zhao Y, Zhao B, et al. MiR-206, a key modulator of skeletal muscle development and disease. Int J Biol Sci. 2015;11(3):345\u201352.","journal-title":"Int J Biol Sci"},{"issue":"1","key":"415_CR61","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1101\/gad.1500707","volume":"21","author":"PL Boutz","year":"2007","unstructured":"Boutz PL, Chawla G, Stoilov P, Black DL. MicroRNAs regulate the expression of the alternative splicing factor nPTB during muscle development. Genes Dev. 2007;21(1):71\u201384.","journal-title":"Genes Dev"},{"issue":"5","key":"415_CR62","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1083\/jcb.200603008","volume":"174","author":"HK Kim","year":"2006","unstructured":"Kim HK, Lee YS, Sivaprasad U, Malhotra A, Dutta A. Muscle-specific microRNA miR-206 promotes muscle differentiation. J Cell Biol. 2006;174(5):677\u201387.","journal-title":"J Cell Biol"},{"key":"415_CR63","doi-asserted-by":"crossref","unstructured":"Trifunov S, Natera-de Benito D, Exposito Escudero JM, Ortez C, Medina J, Cuadras D, et al. Longitudinal study of three microRNAs in Duchenne muscular dystrophy and Becker muscular dystrophy. Front Neurol. 2020;11. Available from: https:\/\/www.frontiersin.org\/journals\/neurology\/articles\/10.3389\/fneur.2020.00304\/full. Cited 2024 May 25.","DOI":"10.3389\/fneur.2020.00304"},{"key":"415_CR64","doi-asserted-by":"crossref","unstructured":"Matsuzaka Y, Kishi S, Aoki Y, Komaki H, Oya Y, Takeda S ichi, et al. Three novel serum biomarkers, miR-1, miR-133a, and miR-206 for Limb-girdle muscular dystrophy, Facioscapulohumeral muscular dystrophy, and Becker muscular dystrophy. Environ Health Prev Med. 2014;19(6):452\u20138.","DOI":"10.1007\/s12199-014-0405-7"},{"key":"415_CR65","doi-asserted-by":"crossref","unstructured":"Nunes AM, Ramirez M, Jones TI, Jones PL. Identification of candidate miRNA biomarkers for facioscapulohumeral muscular dystrophy using DUX4-based mouse models. Dis Model Mech. 2021;14(8):dmm049016.","DOI":"10.1242\/dmm.049016"},{"issue":"6","key":"415_CR66","doi-asserted-by":"publisher","first-page":"2054","DOI":"10.1172\/JCI62656","volume":"122","author":"N Liu","year":"2012","unstructured":"Liu N, Williams AH, Maxeiner JM, Bezprozvannaya S, Shelton JM, Richardson JA, et al. microRNA-206 promotes skeletal muscle regeneration and delays progression of Duchenne muscular dystrophy in mice. J Clin Invest. 2012;122(6):2054\u201365.","journal-title":"J Clin Invest"},{"issue":"12","key":"415_CR67","doi-asserted-by":"publisher","first-page":"1455","DOI":"10.1038\/nm.3990","volume":"21","author":"NA Dumont","year":"2015","unstructured":"Dumont NA, Wang YX, von Maltzahn J, Pasut A, Bentzinger CF, Brun CE, et al. Dystrophin expression in muscle stem cells regulates their polarity and asymmetric division. Nat Med. 2015;21(12):1455\u201363.","journal-title":"Nat Med"},{"issue":"4","key":"415_CR68","doi-asserted-by":"publisher","first-page":"1398","DOI":"10.1016\/j.stemcr.2018.03.009","volume":"10","author":"D Vallejo","year":"2018","unstructured":"Vallejo D, Hern\u00e1ndez-Torres F, Lozano-Velasco E, Rodriguez-Outeiri\u00f1o L, Carvajal A, Creus C, et al. PITX2 Enhances the regenerative potential of dystrophic skeletal muscle stem cells. Stem Cell Rep. 2018;10(4):1398\u2013411.","journal-title":"Stem Cell Rep"},{"key":"415_CR69","doi-asserted-by":"crossref","unstructured":"Rodriguez-Outeiri\u00f1o L, Hernandez-Torres F, Ramirez de Acu\u00f1a F, Rastrojo A, Creus C, Carvajal A, et al. miR-106b is a novel target to promote muscle regeneration and restore satellite stem cell function in injured Duchenne dystrophic muscle. Mol Ther - Nucleic Acids. 2022;29:769\u201386.","DOI":"10.1016\/j.omtn.2022.08.025"},{"issue":"7","key":"415_CR70","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1016\/j.cell.2010.11.039","volume":"143","author":"A Sacco","year":"2010","unstructured":"Sacco A, Mourkioti F, Tran R, Choi J, Llewellyn M, Kraft P, et al. Short telomeres and stem cell exhaustion model Duchenne muscular dystrophy in mdx\/mTR mice. Cell. 2010;143(7):1059\u201371.","journal-title":"Cell"},{"issue":"1","key":"415_CR71","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/npjregenmed.2016.6","volume":"1","author":"NA Dumont","year":"2016","unstructured":"Dumont NA, Rudnicki MA. Targeting muscle stem cell intrinsic defects to treat Duchenne muscular dystrophy. Npj Regen Med. 2016;1(1):1\u20137.","journal-title":"Npj Regen Med"},{"issue":"10","key":"415_CR72","doi-asserted-by":"publisher","first-page":"2495","DOI":"10.1111\/j.1582-4934.2009.00898.x","volume":"14","author":"T Nakasa","year":"2010","unstructured":"Nakasa T, Ishikawa M, Shi M, Shibuya H, Adachi N, Ochi M. Acceleration of muscle regeneration by local injection of muscle-specific microRNAs in rat skeletal muscle injury model. J Cell Mol Med. 2010;14(10):2495\u2013505.","journal-title":"J Cell Mol Med"},{"issue":"5","key":"415_CR73","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1002\/emmm.201100133","volume":"3","author":"D Cacchiarelli","year":"2011","unstructured":"Cacchiarelli D, Legnini I, Martone J, Cazzella V, D\u2019Amico A, Bertini E, et al. MiRNAs as serum biomarkers for Duchenne muscular dystrophy. EMBO Mol Med. 2011;3(5):258\u201365.","journal-title":"EMBO Mol Med"},{"key":"415_CR74","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms9528","volume":"27;6(1)","author":"I Le Roux","year":"2015","unstructured":"Le Roux I, Konge J, Le Cam L, Flamant P, Tajbakhsh S. Numb is required to prevent p53-dependent senescence following skeletal muscle injury. Nat Commun. 2015;27;6(1):8528.","journal-title":"Nat Commun"},{"key":"415_CR75","doi-asserted-by":"crossref","unstructured":"Meng Q, Zhang J, Zhong J, Zeng D, Lan D. Novel miRNA biomarkers for patients with duchenne muscular dystrophy. Front Neurol. 2022 ;13. Available from: https:\/\/www.frontiersin.org\/journals\/neurology\/articles\/10.3389\/fneur.2022.921785\/full. Cited 2024 May 25.","DOI":"10.3389\/fneur.2022.921785"},{"issue":"4","key":"415_CR76","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1128\/MCB.01394-14","volume":"35","author":"M Ballarino","year":"2015","unstructured":"Ballarino M, Cazzella V, D\u2019Andrea D, Grassi L, Bisceglie L, Cipriano A, et al. Novel long noncoding RNAs (lncRNAs) in myogenesis: a miR-31 overlapping lncRNA transcript controls myoblast differentiation. Mol Cell Biol. 2015;35(4):728\u201336.","journal-title":"Mol Cell Biol"},{"issue":"6","key":"415_CR77","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1007\/BF01233096","volume":"16","author":"C Webster","year":"1990","unstructured":"Webster C, Blau HM. Accelerated age-related decline in replicative life-span of Duchenne muscular dystrophy myoblasts: implications for cell and gene therapy. Somat Cell Mol Genet. 1990;16(6):557\u201365.","journal-title":"Somat Cell Mol Genet"},{"issue":"7","key":"415_CR78","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.1016\/j.bbadis.2015.04.013","volume":"1852","author":"S Zanotti","year":"2015","unstructured":"Zanotti S, Gibertini S, Curcio M, Savadori P, Pasanisi B, Morandi L, et al. Opposing roles of miR-21 and miR-29 in the progression of fibrosis in Duchenne muscular dystrophy. Biochim Biophys Acta BBA - Mol Basis Dis. 2015;1852(7):1451\u201364.","journal-title":"Biochim Biophys Acta BBA - Mol Basis Dis"},{"issue":"6","key":"415_CR79","doi-asserted-by":"publisher","first-page":"1222","DOI":"10.1038\/mt.2012.35","volume":"20","author":"L Wang","year":"2012","unstructured":"Wang L, Zhou L, Jiang P, Lu L, Chen X, Lan H, et al. Loss of miR-29 in myoblasts contributes to dystrophic muscle pathogenesis. Mol Ther J Am Soc Gene Ther. 2012;20(6):1222\u201333.","journal-title":"Mol Ther J Am Soc Gene Ther"},{"issue":"6","key":"415_CR80","doi-asserted-by":"publisher","first-page":"e2261","DOI":"10.1038\/cddis.2016.165","volume":"7","author":"M Nie","year":"2016","unstructured":"Nie M, Liu J, Yang Q, Seok HY, Hu X, Deng ZL, et al. MicroRNA-155 facilitates skeletal muscle regeneration by balancing pro- and anti-inflammatory macrophages. Cell Death Dis. 2016;7(6):e2261\u2013e2261.","journal-title":"Cell Death Dis"},{"issue":"2018","key":"415_CR81","doi-asserted-by":"publisher","first-page":"e4814696","DOI":"10.1155\/2018\/4814696","volume":"13","author":"M D\u2019Agostino","year":"2018","unstructured":"D\u2019Agostino M, Torcinaro A, Madaro L, Marchetti L, Sileno S, Beji S, et al. Role of miR-200c in myogenic differentiation impairment via p66Shc: implication in skeletal muscle regeneration of dystrophic mdx Mice. Oxid Med Cell Longev. 2018;13(2018):e4814696.","journal-title":"Oxid Med Cell Longev"},{"issue":"5","key":"415_CR82","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1101\/gad.234419.113","volume":"28","author":"BK Dey","year":"2014","unstructured":"Dey BK, Pfeifer K, Dutta A. The H19 long noncoding RNA gives rise to microRNAs miR-675-3p and miR-675-5p to promote skeletal muscle differentiation and regeneration. Genes Dev. 2014;28(5):491\u2013501.","journal-title":"Genes Dev"},{"issue":"2","key":"415_CR83","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41419-019-1307-9","volume":"10","author":"D Morgoulis","year":"2019","unstructured":"Morgoulis D, Berenstein P, Cazacu S, Kazimirsky G, Dori A, Barnea ER, et al. sPIF promotes myoblast differentiation and utrophin expression while inhibiting fibrosis in Duchenne muscular dystrophy via the H19\/miR-675\/let-7 and miR-21 pathways. Cell Death Dis. 2019;10(2):1\u201310.","journal-title":"Cell Death Dis"},{"issue":"1","key":"415_CR84","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/2044-5040-1-27","volume":"1","author":"MS Alexander","year":"2011","unstructured":"Alexander MS, Casar JC, Motohashi N, Myers JA, Eisenberg I, Gonzalez RT, et al. Regulation of DMD pathology by an ankyrin-encoded miRNA. Skelet Muscle. 2011;1(1):27.","journal-title":"Skelet Muscle"},{"issue":"1","key":"415_CR85","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s42003-021-01952-2","volume":"4","author":"M Fukuoka","year":"2021","unstructured":"Fukuoka M, Fujita H, Numao K, Nakamura Y, Shimizu H, Sekiguchi M, et al. MiR-199-3p enhances muscle regeneration and ameliorates aged muscle and muscular dystrophy. Commun Biol. 2021;4(1):1\u201312.","journal-title":"Commun Biol"},{"key":"415_CR86","doi-asserted-by":"crossref","unstructured":"Kitzmann M, Carnac G, Vandromme M, Primig M, Lamb NJC, Fernandez A. The muscle regulatory factors MyoD and Myf-5 undergo distinct cell cycle\u2013specific expression in muscle cells. J Cell Biol. 1998;142(6):1447\u201359.","DOI":"10.1083\/jcb.142.6.1447"},{"issue":"4","key":"415_CR87","first-page":"498","volume":"45","author":"M Koenig","year":"1989","unstructured":"Koenig M, Beggs AH, Moyer M, Scherpf S, Heindrich K, Bettecken T, et al. The molecular basis for Duchenne versus Becker muscular dystrophy: correlation of severity with type of deletion. Am J Hum Genet. 1989;45(4):498\u2013506.","journal-title":"Am J Hum Genet"},{"issue":"2","key":"415_CR88","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1002\/jcsm.13171","volume":"14","author":"CR Heier","year":"2023","unstructured":"Heier CR, McCormack NM, Tully CB, Novak JS, Newell-Stamper BL, Russell AJ, et al. The X-linked Becker muscular dystrophy (bmx) mouse models Becker muscular dystrophy via deletion of murine dystrophin exons 45-47. J Cachexia Sarcopenia Muscle. 2023;14(2):940\u201354.","journal-title":"J Cachexia Sarcopenia Muscle"},{"issue":"1","key":"415_CR89","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/s13395-018-0161-2","volume":"8","author":"M Guilbaud","year":"2018","unstructured":"Guilbaud M, Gentil C, Peccate C, Gargaun E, Holtzmann I, Gruszczynski C, et al. miR-708-5p and miR-34c-5p are involved in nNOS regulation in dystrophic context. Skelet Muscle. 2018;8(1):15.","journal-title":"Skelet Muscle"},{"issue":"9","key":"415_CR90","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics10090713","volume":"10","author":"R Marozzo","year":"2020","unstructured":"Marozzo R, Pegoraro V, Angelini C. MiRNAs, myostatin, and muscle MRI imaging as biomarkers of clinical features in Becker muscular dystrophy. Diagnostics. 2020;10(9):713.","journal-title":"Diagnostics"},{"issue":"10","key":"415_CR91","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1016\/S1474-4422(12)70204-1","volume":"11","author":"B Udd","year":"2012","unstructured":"Udd B, Krahe R. The myotonic dystrophies: molecular, clinical, and therapeutic challenges. Lancet Neurol. 2012;11(10):891\u2013905.","journal-title":"Lancet Neurol"},{"issue":"23","key":"415_CR92","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.omtm.2021.09.007","volume":"10","author":"D Koutalianos","year":"2021","unstructured":"Koutalianos D, Koutsoulidou A, Mytidou C, Kakouri AC, Oulas A, Tomazou M, et al. miR-223-3p and miR-24-3p as novel serum-based biomarkers for myotonic dystrophy type 1. Mol Ther Methods Clin Dev. 2021;10(23):169\u201383.","journal-title":"Mol Ther Methods Clin Dev"},{"issue":"155","key":"415_CR93","doi-asserted-by":"publisher","first-page":"1432","DOI":"10.1016\/j.ijbiomac.2019.11.119","volume":"15","author":"R Yao","year":"2020","unstructured":"Yao R, Yao Y, Li C, Li X, Ni W, Quan R, et al. Circ-HIPK3 plays an active role in regulating myoblast differentiation. Int J Biol Macromol. 2020;15(155):1432\u20139.","journal-title":"Int J Biol Macromol"},{"issue":"1","key":"415_CR94","doi-asserted-by":"publisher","first-page":"11215","DOI":"10.1038\/ncomms11215","volume":"7","author":"Q Zheng","year":"2016","unstructured":"Zheng Q, Bao C, Guo W, Li S, Chen J, Chen B, et al. Circular RNA profiling reveals an abundant circHIPK3 that regulates cell growth by sponging multiple miRNAs. Nat Commun. 2016;7(1):11215.","journal-title":"Nat Commun"},{"issue":"2","key":"415_CR95","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.nmd.2010.11.012","volume":"21","author":"R Perbellini","year":"2011","unstructured":"Perbellini R, Greco S, Sarra-Ferraris G, Cardani R, Capogrossi MC, Meola G, et al. Dysregulation and cellular mislocalization of specific miRNAs in myotonic dystrophy type 1. Neuromuscul Disord. 2011;21(2):81\u20138.","journal-title":"Neuromuscul Disord"},{"issue":"6","key":"415_CR96","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0039732","volume":"7","author":"S Greco","year":"2012","unstructured":"Greco S, Perfetti A, Fasanaro P, Cardani R, Capogrossi MC, Meola G, et al. Deregulated microRNAs in myotonic dystrophy Type 2. PLoS ONE. 2012;7(6):e39732.","journal-title":"PLoS ONE"},{"issue":"4","key":"415_CR97","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1093\/hmg\/dds478","volume":"22","author":"JM Fernandez-Costa","year":"2013","unstructured":"Fernandez-Costa JM, Garcia-Lopez A, Zu\u00f1iga S, Fernandez-Pedrosa V, Felipo-Benavent A, Mata M, et al. Expanded CTG repeats trigger miRNA alterations in Drosophila that are conserved in myotonic dystrophy type 1 patients. Hum Mol Genet. 2013;22(4):704\u201316.","journal-title":"Hum Mol Genet"},{"issue":"7","key":"415_CR98","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1038\/nsmb.2067","volume":"18","author":"F Rau","year":"2011","unstructured":"Rau F, Freyermuth F, Fugier C, Villemin JP, Fischer MC, Jost B, et al. Misregulation of miR-1 processing is associated with heart defects in myotonic dystrophy. Nat Struct Mol Biol. 2011;18(7):840\u20135.","journal-title":"Nat Struct Mol Biol"},{"issue":"10","key":"415_CR99","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41419-020-03112-6","volume":"11","author":"X Shen","year":"2020","unstructured":"Shen X, Xu F, Li M, Wu S, Zhang J, Wang A, et al. miR-322\/-503 rescues myoblast defects in myotonic dystrophy type 1 cell model by targeting CUG repeats. Cell Death Dis. 2020;11(10):1\u201317.","journal-title":"Cell Death Dis"},{"issue":"1","key":"415_CR100","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1093\/toxres\/tfaa096","volume":"10","author":"W Dong","year":"2021","unstructured":"Dong W, Liu Q, Wang ZC, Du XX, Liu LL, Wang N, et al. miR-322\/miR-503 clusters regulate defective myoblast differentiation in myotonic dystrophy RNA-toxic by targeting Celf1. Toxicol Res. 2021;10(1):29\u201339.","journal-title":"Toxicol Res"},{"issue":"1","key":"415_CR101","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1080\/01616412.2018.1493963","volume":"41","author":"W Dong","year":"2019","unstructured":"Dong W, Chen X, Wang M, Zheng Z, Zhang X, Xiao Q, et al. Mir-206 partially rescues myogenesis deficiency by inhibiting CUGBP1 accumulation in the cell models of myotonic dystrophy. Neurol Res. 2019;41(1):9\u201318.","journal-title":"Neurol Res"},{"issue":"8","key":"415_CR102","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1016\/S0960-8966(01)00226-7","volume":"11","author":"D Furling","year":"2001","unstructured":"Furling D, Lemieux D, Taneja K, Puymirat J. Decreased levels of myotonic dystrophy protein kinase (DMPK) and delayed differentiation in human myotonic dystrophy myoblasts. Neuromuscul Disord. 2001;11(8):728\u201335.","journal-title":"Neuromuscul Disord"},{"issue":"10","key":"415_CR103","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0108411","volume":"9","author":"V Colangelo","year":"2014","unstructured":"Colangelo V, Fran\u00e7ois S, Sold\u00e0 G, Picco R, Roma F, Ginelli E, et al. Next-generation sequencing analysis of MiRNA expression in control and FSHD myogenesis. PLoS ONE. 2014;9(10):e108411.","journal-title":"PLoS ONE"},{"issue":"49","key":"415_CR104","doi-asserted-by":"publisher","first-page":"34989","DOI":"10.1074\/jbc.M113.504522","volume":"288","author":"P Dmitriev","year":"2013","unstructured":"Dmitriev P, Stankevicins L, Ansseau E, Petrov A, Barat A, Dessen P, et al. Defective regulation of microRNA target genes in myoblasts from facioscapulohumeral dystrophy patients *. J Biol Chem. 2013;288(49):34989\u20135002.","journal-title":"J Biol Chem"},{"issue":"2","key":"415_CR105","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0116853","volume":"10","author":"DM Portilho","year":"2015","unstructured":"Portilho DM, Alves MR, Kratassiouk G, Roche S, Magdinier F, de Santana EC, et al. miRNA expression in control and FSHD fetal human muscle biopsies. PLoS ONE. 2015;10(2):e0116853.","journal-title":"PLoS ONE"},{"issue":"11","key":"415_CR106","doi-asserted-by":"publisher","first-page":"3966","DOI":"10.1096\/fj.11-182915","volume":"25","author":"N Sylvius","year":"2011","unstructured":"Sylvius N, Bonne G, Straatman K, Reddy T, Gant TW, Shackleton S. MicroRNA expression profiling in patients with lamin A\/C-associated muscular dystrophy. FASEB J. 2011;25(11):3966\u201378.","journal-title":"FASEB J"},{"key":"415_CR107","doi-asserted-by":"crossref","unstructured":"Oliveira MT de JS, da Silva Santana TAB, Costa MCM, Borges GF, de Miranda FS, Slaibi-Filho J, et al. MicroRNA as potential biomarker for severity, progression, and therapeutic monitoring in animal models of limb-girdle muscular dystrophy: a systematic review. Front Cell Neurosci. 2023;17. Available from: https:\/\/www.frontiersin.org\/articles\/10.3389\/fncel.2023.1233181. Cited 2024 May 25.","DOI":"10.3389\/fncel.2023.1233181"},{"issue":"2","key":"415_CR108","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1016\/j.bbrc.2015.03.150","volume":"461","author":"R Wu","year":"2015","unstructured":"Wu R, Li H, Li T, Zhang Y, Zhu D. Myostatin regulates miR-431 expression via the Ras-Mek-Erk signaling pathway. Biochem Biophys Res Commun. 2015;461(2):224\u20139.","journal-title":"Biochem Biophys Res Commun"},{"issue":"2","key":"415_CR109","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0055281","volume":"8","author":"N Vignier","year":"2013","unstructured":"Vignier N, Amor F, Fogel P, Duvallet A, Poupiot J, Charrier S, et al. Distinctive serum miRNA profile in mouse models of striated muscular pathologies. PLoS ONE. 2013;8(2):e55281.","journal-title":"PLoS ONE"},{"issue":"6","key":"415_CR110","doi-asserted-by":"publisher","first-page":"1975","DOI":"10.2353\/ajpath.2006.051316","volume":"168","author":"SA Parsons","year":"2006","unstructured":"Parsons SA, Millay DP, Sargent MA, McNally EM, Molkentin JD. Age-dependent effect of myostatin blockade on disease severity in a murine model of limb-girdle muscular dystrophy. Am J Pathol. 2006;168(6):1975\u201385.","journal-title":"Am J Pathol"},{"issue":"17","key":"415_CR111","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21176059","volume":"21","author":"V Raz","year":"2020","unstructured":"Raz V, Kroon RHMJM, Mei H, Riaz M, Buermans H, Lassche S, et al. Age-associated salivary microRNA biomarkers for oculopharyngeal muscular dystrophy. Int J Mol Sci. 2020;21(17):6059.","journal-title":"Int J Mol Sci"},{"issue":"5","key":"415_CR112","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1002\/jcsm.12438","volume":"10","author":"P Harish","year":"2019","unstructured":"Harish P, Malerba A, Lu-Nguyen N, Forrest L, Cappellari O, Roth F, et al. Inhibition of myostatin improves muscle atrophy in oculopharyngeal muscular dystrophy (OPMD). J Cachexia Sarcopenia Muscle. 2019;10(5):1016\u201326.","journal-title":"J Cachexia Sarcopenia Muscle"},{"issue":"13","key":"415_CR113","doi-asserted-by":"publisher","first-page":"5647","DOI":"10.1093\/nar\/gkr145","volume":"39","author":"BA Hurschler","year":"2011","unstructured":"Hurschler BA, Harris DT, Grosshans H. The type II poly(A)-binding protein PABP-2 genetically interacts with the let-7 miRNA and elicits heterochronic phenotypes in Caenorhabditis elegans. Nucleic Acids Res. 2011;39(13):5647\u201357.","journal-title":"Nucleic Acids Res"},{"issue":"2","key":"415_CR114","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1038\/ng0298-164","volume":"18","author":"B Brais","year":"1998","unstructured":"Brais B, Bouchard JP, Xie YG, Rochefort DL, Chr\u00e9tien N, Tom\u00e9 FM, et al. Short GCG expansions in the PABP2 gene cause oculopharyngeal muscular dystrophy. Nat Genet. 1998;18(2):164\u20137.","journal-title":"Nat Genet"},{"issue":"6","key":"415_CR115","doi-asserted-by":"publisher","first-page":"7155","DOI":"10.1096\/fj.201801577RR","volume":"33","author":"C Cappelletti","year":"2019","unstructured":"Cappelletti C, Galbardi B, Bruttini M, Salerno F, Canioni E, Pasanisi MB, et al. Aging-associated genes and let-7 microRNAs: a contribution to myogenic program dysregulation in oculopharyngeal muscular dystrophy. FASEB J. 2019;33(6):7155\u201367.","journal-title":"FASEB J"},{"issue":"3","key":"415_CR116","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1007\/s00223-014-9915-y","volume":"96","author":"WR Frontera","year":"2015","unstructured":"Frontera WR, Ochala J. Skeletal muscle: a brief review of structure and function. Calcif Tissue Int. 2015;96(3):183\u201395.","journal-title":"Calcif Tissue Int"},{"issue":"4","key":"415_CR117","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1016\/j.bbadis.2014.07.023","volume":"1852","author":"V Nigro","year":"2015","unstructured":"Nigro V, Piluso G. Spectrum of muscular dystrophies associated with sarcolemmal-protein genetic defects. Biochim Biophys Acta. 2015;1852(4):585\u201393.","journal-title":"Biochim Biophys Acta"},{"key":"415_CR118","unstructured":"Chhetri S. Roles of miR-137 in muscular dystrophy and muscular dystrophy-related phenotypes in Drosophila melanogaster [doctoralThesis]. 2019. Available from: https:\/\/ediss.uni-goettingen.de\/handle\/11858\/00-1735-0000-002E-E624-1.  Cited 2024 May 25."},{"issue":"5","key":"415_CR119","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1101\/gad.1519207","volume":"21","author":"X Cao","year":"2007","unstructured":"Cao X, Pfaff SL, Gage FH. A functional study of miR-124 in the developing neural tube. Genes Dev. 2007;21(5):531.","journal-title":"Genes Dev"},{"issue":"12","key":"415_CR120","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0029376","volume":"6","author":"U Basu","year":"2011","unstructured":"Basu U, Lozynska O, Moorwood C, Patel G, Wilton SD, Khurana TS. Translational regulation of utrophin by miRNAs. PLoS ONE. 2011;6(12):e29376.","journal-title":"PLoS ONE"},{"issue":"5","key":"415_CR121","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1038\/nm1582","volume":"13","author":"A Car\u00e8","year":"2007","unstructured":"Car\u00e8 A, Catalucci D, Felicetti F, Bonci D, Addario A, Gallo P, et al. MicroRNA-133 controls cardiac hypertrophy. Nat Med. 2007;13(5):613\u20138.","journal-title":"Nat Med"},{"key":"415_CR122","doi-asserted-by":"crossref","unstructured":"Callis TE, Pandya K, Seok HY, Tang RH, Tatsuguchi M, Huang ZP, et al. MicroRNA-208a is a regulator of cardiac hypertrophy and conduction in mice. J Clin Invest. 2009;119(9):2772\u201386.","DOI":"10.1172\/JCI36154"},{"issue":"2","key":"415_CR123","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.yexcr.2017.09.007","volume":"360","author":"Y Liu","year":"2017","unstructured":"Liu Y, Li G. Zhang J fang. Exp Cell Res. 2017;360(2):61\u20135.","journal-title":"Exp Cell Res"},{"issue":"4","key":"415_CR124","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1055\/s-0035-1558982","volume":"35","author":"JF Brandsema","year":"2015","unstructured":"Brandsema JF, Darras BT. Dystrophinopathies. Semin Neurol. 2015;35(4):369\u201384.","journal-title":"Semin Neurol"},{"issue":"5","key":"415_CR125","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1083\/jcb.200406181","volume":"166","author":"AJ Kee","year":"2004","unstructured":"Kee AJ, Schevzov G, Nair-Shalliker V, Robinson CS, Vrhovski B, Ghoddusi M, et al. Sorting of a nonmuscle tropomyosin to a novel cytoskeletal compartment in skeletal muscle results in muscular dystrophy. J Cell Biol. 2004;166(5):685\u201396.","journal-title":"J Cell Biol"},{"issue":"5","key":"415_CR126","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1007\/s004240050696","volume":"436","author":"J Komulainen","year":"1998","unstructured":"Komulainen J, Takala TES, Kuipers H, Hesselink MKC. The disruption of myofibre structures in rat skeletal muscle after forced lengthening contractions. Pfl\u00fcg Arch. 1998;436(5):735\u201341.","journal-title":"Pfl\u00fcg Arch"},{"issue":"3","key":"415_CR127","doi-asserted-by":"publisher","first-page":"C209","DOI":"10.1152\/ajpcell.00185.2016","volume":"312","author":"A Amirouche","year":"2017","unstructured":"Amirouche A, Jahnke VE, Lunde JA, Koulmann N, Freyssenet DG, Jasmin BJ. Muscle-specific microRNA-206 targets multiple components in dystrophic skeletal muscle representing beneficial adaptations. Am J Physiol Cell Physiol. 2017;312(3):C209\u201321.","journal-title":"Am J Physiol Cell Physiol"},{"issue":"8","key":"415_CR128","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0073224","volume":"8","author":"EK Johnson","year":"2013","unstructured":"Johnson EK, Li B, Yoon JH, Flanigan KM, Martin PT, Ervasti J, et al. Identification of new dystroglycan complexes in skeletal muscle. PLoS ONE. 2013;8(8):e73224.","journal-title":"PLoS ONE"},{"issue":"20","key":"415_CR129","doi-asserted-by":"publisher","first-page":"4508","DOI":"10.1093\/hmg\/dds293","volume":"21","author":"G Miller","year":"2012","unstructured":"Miller G, Moore CJ, Terry R, La Riviere T, Mitchell A, Piggott R, et al. Preventing phosphorylation of dystroglycan ameliorates the dystrophic phenotype in mdx mouse. Hum Mol Genet. 2012;21(20):4508\u201320.","journal-title":"Hum Mol Genet"},{"key":"415_CR130","doi-asserted-by":"crossref","unstructured":"Parton RG. Caveolae: structure, function, and relationship to disease. Annu Rev Cell Dev Biol. 2018;34(2018):111\u201336.","DOI":"10.1146\/annurev-cellbio-100617-062737"},{"issue":"2","key":"415_CR131","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1007\/s10555-020-09890-x","volume":"39","author":"L Sim\u00f3n","year":"2020","unstructured":"Sim\u00f3n L, Campos A, Leyton L, Quest AFG. Caveolin-1 function at the plasma membrane and in intracellular compartments in cancer. Cancer Metastasis Rev. 2020;39(2):435\u201353.","journal-title":"Cancer Metastasis Rev"},{"issue":"6","key":"415_CR132","doi-asserted-by":"publisher","DOI":"10.3390\/cells12060942","volume":"12","author":"L Sotodosos-Alonso","year":"2023","unstructured":"Sotodosos-Alonso L, Pulgar\u00edn-Alfaro M, del Pozo MA. Caveolae mechanotransduction at the interface between cytoskeleton and extracellular matrix. Cells. 2023;12(6):942.","journal-title":"Cells"},{"key":"415_CR133","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.matbio.2018.07.003","volume":"74","author":"S Zanotti","year":"2018","unstructured":"Zanotti S, Gibertini S, Blasevich F, Bragato C, Ruggieri A, Saredi S, et al. Exosomes and exosomal miRNAs from muscle-derived fibroblasts promote skeletal muscle fibrosis. Matrix Biol. 2018;74:77\u2013100.","journal-title":"Matrix Biol"},{"issue":"8","key":"415_CR134","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1016\/j.matbio.2007.06.004","volume":"26","author":"S Zanotti","year":"2007","unstructured":"Zanotti S, Saredi S, Ruggieri A, Fabbri M, Blasevich F, Romaggi S, et al. Altered extracellular matrix transcript expression and protein modulation in primary Duchenne muscular dystrophy myotubes. Matrix Biol. 2007;26(8):615\u201324.","journal-title":"Matrix Biol"},{"issue":"5","key":"415_CR135","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1111\/j.1745-7599.2009.00404.x","volume":"21","author":"RW Kaspar","year":"2009","unstructured":"Kaspar RW, Allen HD, Montanaro F. Current understanding and management of dilated cardiomyopathy in Duchenne and Becker muscular dystrophy. J Am Acad Nurse Pract. 2009;21(5):241\u20139.","journal-title":"J Am Acad Nurse Pract"},{"issue":"2","key":"415_CR136","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.113.000078","volume":"2","author":"I Karakikes","year":"2013","unstructured":"Karakikes I, Chaanine AH, Kang S, Mukete BN, Jeong D, Zhang S, et al. Therapeutic cardiac-targeted delivery of miR-1 reverses pressure overload-induced cardiac hypertrophy and attenuates pathological remodeling. J Am Heart Assoc. 2013;2(2):e000078.","journal-title":"J Am Heart Assoc"},{"issue":"1","key":"415_CR137","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.hrtlng.2020.07.010","volume":"50","author":"DM Li","year":"2021","unstructured":"Li DM, Li BX, Yang LJ, Gao P, Ma ZY, Li ZJ. Diagnostic value of circulating microRNA-208a in differentiation of preserved from reduced ejection fraction heart failure. Heart Lung. 2021;50(1):71\u20134.","journal-title":"Heart Lung"},{"issue":"23","key":"415_CR138","doi-asserted-by":"publisher","first-page":"2347","DOI":"10.1093\/hmg\/ddab199","volume":"30","author":"M Gartz","year":"2021","unstructured":"Gartz M, Beatka M, Prom MJ, Strande JL, Lawlor MW. Cardiomyocyte-produced miR-339-5p mediates pathology in Duchenne muscular dystrophy cardiomyopathy. Hum Mol Genet. 2021;30(23):2347\u201361.","journal-title":"Hum Mol Genet"},{"issue":"1","key":"415_CR139","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1111\/j.1750-3639.1996.tb00781.x","volume":"6","author":"DJ Blake","year":"1996","unstructured":"Blake DJ, Tinsley JM, Davies KE. Utrophin: a structural and functional comparison to dystrophin. Brain Pathol. 1996;6(1):37\u201347.","journal-title":"Brain Pathol"},{"issue":"12","key":"415_CR140","doi-asserted-by":"publisher","first-page":"1441","DOI":"10.1038\/4033","volume":"4","author":"J Tinsley","year":"1998","unstructured":"Tinsley J, Deconinck N, Fisher R, Kahn D, Phelps S, Gillis JM, et al. Expression of full-length utrophin prevents muscular dystrophy in mdx mice. Nat Med. 1998;4(12):1441\u20134.","journal-title":"Nat Med"},{"key":"415_CR141","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2015.00069","volume":"7","author":"L Pelosi","year":"2015","unstructured":"Pelosi L, Coggi A, Forcina L, Musar\u00f2 A. MicroRNAs modulated by local mIGF-1 expression in mdx dystrophic mice. Front Aging Neurosci. 2015;7:69.","journal-title":"Front Aging Neurosci"},{"issue":"10","key":"415_CR142","doi-asserted-by":"publisher","first-page":"1623","DOI":"10.1093\/hmg\/ddl083","volume":"15","author":"KA Kleopa","year":"2006","unstructured":"Kleopa KA, Drousiotou A, Mavrikiou E, Ormiston A, Kyriakides T. Naturally occurring utrophin correlates with disease severity in Duchenne muscular dystrophy. Hum Mol Genet. 2006;15(10):1623\u20138.","journal-title":"Hum Mol Genet"},{"issue":"3","key":"415_CR143","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1016\/j.gde.2011.02.001","volume":"21","author":"C Godfrey","year":"2011","unstructured":"Godfrey C, Foley AR, Clement E, Muntoni F. Dystroglycanopathies: coming into focus. Curr Opin Genet Dev. 2011;21(3):278\u201385.","journal-title":"Curr Opin Genet Dev"},{"issue":"8","key":"415_CR144","doi-asserted-by":"publisher","first-page":"55R","DOI":"10.1093\/glycob\/cwg076","volume":"13","author":"PT Martin","year":"2003","unstructured":"Martin PT. Dystroglycan glycosylation and its role in matrix binding in skeletal muscle. Glycobiology. 2003;13(8):55R-66R.","journal-title":"Glycobiology"},{"key":"415_CR145","doi-asserted-by":"crossref","unstructured":"Yatsenko A, Marrone A, Shcherbata H. MiRNA-based buffering of the cobblestone-lissencephaly-associated extracellular matrix receptor dystroglycan via its alternative 3\u2032-UTR. Nat Commun. 2014;5:4906.","DOI":"10.1038\/ncomms5906"},{"issue":"2","key":"415_CR146","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1093\/brain\/awr357","volume":"135","author":"L Devisme","year":"2012","unstructured":"Devisme L, Bouchet C, Gonzal\u00e8s M, Alanio E, Bazin A, Bessi\u00e8res B, et al. Cobblestone lissencephaly: neuropathological subtypes and correlations with genes of dystroglycanopathies. Brain. 2012;135(2):469\u201382.","journal-title":"Brain"},{"issue":"1","key":"415_CR147","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/jb\/mvu066","volume":"157","author":"T Endo","year":"2015","unstructured":"Endo T. Glycobiology of \u03b1-dystroglycan and muscular dystrophy. J Biochem (Tokyo). 2015;157(1):1\u201312.","journal-title":"J Biochem (Tokyo)"},{"issue":"2","key":"415_CR148","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1016\/S0002-9440(10)63160-4","volume":"164","author":"SC Brown","year":"2004","unstructured":"Brown SC, Torelli S, Brockington M, Yuva Y, Jimenez C, Feng L, et al. Abnormalities in \u03b1-dystroglycan expression in MDC1C and LGMD2I muscular dystrophies. Am J Pathol. 2004;164(2):727\u201337.","journal-title":"Am J Pathol"},{"issue":"2","key":"415_CR149","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1111\/j.1365-2990.2004.00555.x","volume":"30","author":"SH Laval","year":"2004","unstructured":"Laval SH, Bushby KMD. Limb-girdle muscular dystrophies\u2014from genetics to molecular pathology. Neuropathol Appl Neurobiol. 2004;30(2):91\u2013105.","journal-title":"Neuropathol Appl Neurobiol"},{"issue":"2","key":"415_CR150","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1038\/ng1095-216","volume":"11","author":"A Helbling-Leclerc","year":"1995","unstructured":"Helbling-Leclerc A, Zhang X, Topaloglu H, Cruaud C, Tesson F, Weissenbach J, et al. Mutations in the laminin alpha 2-chain gene (LAMA2) cause merosin-deficient congenital muscular dystrophy. Nat Genet. 1995;11(2):216\u20138.","journal-title":"Nat Genet"},{"key":"415_CR151","doi-asserted-by":"crossref","unstructured":"Moreira Soares Oliveira B, Gawlik KI, Durbeej M, Holmberg J. Exploratory profiling of urine MicroRNAs in the dy2J\/dy2J mouse model of LAMA2-CMD: relation to disease progression. PLoS Curr. 2018;10:ecurrents.md.d0c203c018bc024f2f4c9791ecb05f88.","DOI":"10.1371\/currents.md.d0c203c018bc024f2f4c9791ecb05f88"},{"issue":"15","key":"415_CR152","doi-asserted-by":"publisher","first-page":"5874","DOI":"10.1073\/pnas.0801130105","volume":"105","author":"S Sengupta","year":"2008","unstructured":"Sengupta S, den Boon JA, Chen IH, Newton MA, Stanhope SA, Cheng YJ, et al. MicroRNA 29c is down-regulated in nasopharyngeal carcinomas, up-regulating mRNAs encoding extracellular matrix proteins. Proc Natl Acad Sci U S A. 2008;105(15):5874\u20138.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"7","key":"415_CR153","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1242\/jcs.081513","volume":"124","author":"S Valastyan","year":"2011","unstructured":"Valastyan S, Weinberg RA. Roles for microRNAs in the regulation of cell adhesion molecules. J Cell Sci. 2011;124(7):999\u20131006.","journal-title":"J Cell Sci"},{"issue":"5","key":"415_CR154","doi-asserted-by":"publisher","DOI":"10.3390\/cells8050459","volume":"8","author":"C Liu","year":"2019","unstructured":"Liu C, Li L, Ge M, Gu L, Wang M, Zhang K, et al. Overexpression of miR-29 leads to myopathy that resemble pathology of Ullrich congenital muscular dystrophy. Cells. 2019;8(5):459.","journal-title":"Cells"},{"issue":"12","key":"415_CR155","doi-asserted-by":"publisher","first-page":"2333","DOI":"10.1093\/hmg\/ddr126","volume":"20","author":"A Kumar","year":"2011","unstructured":"Kumar A, Yamauchi J, Girgenrath T, Girgenrath M. Muscle-specific expression of insulin-like growth factor 1 improves outcome in Lama2Dy-w mice, a model for congenital muscular dystrophy type 1A. Hum Mol Genet. 2011;20(12):2333\u201343.","journal-title":"Hum Mol Genet"},{"key":"415_CR156","doi-asserted-by":"crossref","unstructured":"Li Z fang, Shelton GD, Engvall E. Elimination of myostatin does not combat muscular dystrophy in dy mice but increases postnatal lethality. Am J Pathol. 2005;166(2):491\u20137.","DOI":"10.1016\/S0002-9440(10)62271-7"},{"issue":"1","key":"415_CR157","first-page":"3","volume":"34","author":"G Siciliano","year":"2015","unstructured":"Siciliano G, Simoncini C, Giannotti S, Zampa V, Angelini C, Ricci G. Muscle exercise in limb girdle muscular dystrophies: pitfall and advantages. Acta Myol Myopathies Cardiomyopathies Off J Mediterr Soc Myol. 2015;34(1):3\u20138.","journal-title":"Acta Myol Myopathies Cardiomyopathies Off J Mediterr Soc Myol"},{"issue":"6","key":"415_CR158","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1002\/cbf.3202","volume":"34","author":"M Aguennouz","year":"2016","unstructured":"Aguennouz M, Lo Giudice C, Licata N, Rodolico C, Musumeci O, Fanin M, et al. MicroRNA signatures predict dysregulated vitamin D receptor and calcium pathways status in limb girdle muscle dystrophies (LGMD) 2A\/2B. Cell Biochem Funct. 2016;34(6):414\u201322.","journal-title":"Cell Biochem Funct"},{"issue":"4","key":"415_CR159","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.113.000284","volume":"2","author":"M Quattrocelli","year":"2013","unstructured":"Quattrocelli M, Crippa S, Montecchiani C, Camps J, Cornaglia AI, Boldrin L, et al. Long-term miR-669a therapy alleviates chronic dilated cardiomyopathy in dystrophic mice. J Am Heart Assoc. 2013;2(4):e000284.","journal-title":"J Am Heart Assoc"},{"key":"415_CR160","doi-asserted-by":"crossref","unstructured":"Wallace GQ, McNally EM. Mechanisms of muscle degeneration, regeneration, and repair in the muscular dystrophies. Annu Rev Physiol. 2009;71(2009):37\u201357.","DOI":"10.1146\/annurev.physiol.010908.163216"},{"issue":"8","key":"415_CR161","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1101\/gad.234468.113","volume":"28","author":"V Saccone","year":"2014","unstructured":"Saccone V, Consalvi S, Giordani L, Mozzetta C, Barozzi I, Sandon\u00e1 M, et al. HDAC-regulated myomiRs control BAF60 variant exchange and direct the functional phenotype of fibro-adipogenic progenitors in dystrophic muscles. Genes Dev. 2014;28(8):841\u201357.","journal-title":"Genes Dev"},{"issue":"4","key":"415_CR162","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/j.cmet.2010.07.008","volume":"12","author":"D Cacchiarelli","year":"2010","unstructured":"Cacchiarelli D, Martone J, Girardi E, Cesana M, Incitti T, Morlando M, et al. MicroRNAs involved in molecular circuitries relevant for the Duchenne muscular dystrophy pathogenesis are controlled by the dystrophin\/nNOS pathway. Cell Metab. 2010;12(4):341\u201351.","journal-title":"Cell Metab"},{"issue":"4","key":"415_CR163","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1161\/CIRCRESAHA.108.181651","volume":"104","author":"D Terentyev","year":"2009","unstructured":"Terentyev D, Belevych AE, Terentyeva R, Martin MM, Malana GE, Kuhn DE, et al. MiR-1 overexpression enhances Ca2+ release and promotes cardiac arrhythmogenesis by targeting PP2A regulatory subunit B56\u03b1 and causing CaMKII-dependent hyperphosphorylation of RyR2. Circ Res. 2009;104(4):514\u201321.","journal-title":"Circ Res"},{"issue":"1","key":"415_CR164","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1083\/jcb.201105013","volume":"196","author":"E Ardite","year":"2012","unstructured":"Ardite E, Perdiguero E, Vidal B, Gutarra S, Serrano AL, Mu\u00f1oz-C\u00e1noves P. PAI-1\u2013regulated miR-21 defines a novel age-associated fibrogenic pathway in muscular dystrophy. J Cell Biol. 2012;196(1):163\u201375.","journal-title":"J Cell Biol"},{"issue":"9","key":"415_CR165","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1055\/s-0032-1333284","volume":"34","author":"HY Li","year":"2013","unstructured":"Li HY, Zhang QG, Chen JW, Chen SQ, Chen SY. The fibrotic role of phosphatidylinositol-3-kinase\/Akt pathway in injured skeletal muscle after acute contusion. Int J Sports Med. 2013;34(9):789\u201394.","journal-title":"Int J Sports Med"},{"key":"415_CR166","first-page":"26","volume":"1","author":"D Jeong","year":"2017","unstructured":"Jeong D, Yoo J, Lee P, Kepreotis S, Lee A, Wahlquist C, et al. MiR-25 Tough decoy enhances cardiac function in heart failure. Mol Ther. 2017;1:26.","journal-title":"Mol Ther"},{"key":"415_CR167","doi-asserted-by":"publisher","DOI":"10.1016\/j.yexmp.2020.104384","volume":"114","author":"Z Huang","year":"2020","unstructured":"Huang Z, Pang G, Huang YG, Li C. miR-133 inhibits proliferation and promotes apoptosis by targeting LASP1 in lupus nephritis. Exp Mol Pathol. 2020;114:104384.","journal-title":"Exp Mol Pathol"},{"issue":"7","key":"415_CR168","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1016\/j.stem.2021.04.008","volume":"28","author":"MN Wosczyna","year":"2021","unstructured":"Wosczyna MN, Carbajal EEP, Wagner MW, Paredes S, Konishi CT, Liu L, et al. Targeting microRNA-mediated gene repression limits adipogenic conversion of skeletal muscle mesenchymal stromal cells. Cell Stem Cell. 2021;28(7):1323-1334.e8.","journal-title":"Cell Stem Cell"},{"issue":"7","key":"415_CR169","doi-asserted-by":"publisher","first-page":"1832","DOI":"10.3390\/cells10071832","volume":"10","author":"N Arrighi","year":"2021","unstructured":"Arrighi N, Moratal C, Savary G, Fassy J, Nottet N, Pons N, et al. The FibromiR miR-214-3p is upregulated in duchenne muscular dystrophy and promotes differentiation of human fibro-adipogenic muscle progenitors. Cells. 2021;10(7):1832.","journal-title":"Cells"},{"issue":"4","key":"415_CR170","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1111\/os.13232","volume":"14","author":"Y Tian","year":"2022","unstructured":"Tian Y, Wang T, Bu H, Shao G, Zhang W, Zhang L. Role of exosomal miR-223 in chronic skeletal muscle inflammation. Orthop Surg. 2022;14(4):644\u201351.","journal-title":"Orthop Surg"},{"issue":"1","key":"415_CR171","doi-asserted-by":"publisher","first-page":"7128","DOI":"10.1038\/s41467-021-27430-1","volume":"12","author":"NY Saad","year":"2021","unstructured":"Saad NY, Al-Kharsan M, Garwick-Coppens SE, Chermahini GA, Harper MA, Palo A, et al. Human miRNA miR-675 inhibits DUX4 expression and may be exploited as a potential treatment for Facioscapulohumeral muscular dystrophy. Nat Commun. 2021;12(1):7128.","journal-title":"Nat Commun"},{"issue":"1","key":"415_CR172","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/s12915-018-0501-z","volume":"16","author":"R Boursereau","year":"2018","unstructured":"Boursereau R, Abou-Samra M, Lecompte S, Noel L, Brichard SM. Downregulation of the NLRP3 inflammasome by adiponectin rescues Duchenne muscular dystrophy. BMC Biol. 2018;16(1):33.","journal-title":"BMC Biol"},{"issue":"4","key":"415_CR173","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41419-022-04804-x","volume":"13","author":"HAN Soliman","year":"2022","unstructured":"Soliman HAN, Toso EA, Darwish IE, Ali SM, Kyba M. Antiapoptotic protein FAIM2 is targeted by miR-3202, and DUX4 via TRIM21, leading to cell death and defective myogenesis. Cell Death Dis. 2022;13(4):1\u201313.","journal-title":"Cell Death Dis"},{"issue":"12","key":"415_CR174","doi-asserted-by":"publisher","first-page":"1822","DOI":"10.1038\/s41591-019-0675-0","volume":"25","author":"D Furman","year":"2019","unstructured":"Furman D, Campisi J, Verdin E, Carrera-Bastos P, Targ S, Franceschi C, et al. Chronic inflammation in the etiology of disease across the life span. Nat Med. 2019;25(12):1822\u201332.","journal-title":"Nat Med"},{"key":"415_CR175","doi-asserted-by":"crossref","unstructured":"Nitahara-Kasahara Y, Takeda S, Okada T. Inflammatory predisposition predicts disease phenotypes in muscular dystrophy. Inflamm Regen. 2016;36(1):14.","DOI":"10.1186\/s41232-016-0019-0"},{"issue":"1","key":"415_CR176","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/s40478-022-01320-z","volume":"10","author":"N Becker","year":"2022","unstructured":"Becker N, Moore SA, Jones KA. The inflammatory pathology of dysferlinopathy is distinct from calpainopathy, Becker muscular dystrophy, and inflammatory myopathies. Acta Neuropathol Commun. 2022;10(1):17.","journal-title":"Acta Neuropathol Commun"},{"issue":"11","key":"415_CR177","doi-asserted-by":"publisher","first-page":"2136","DOI":"10.1212\/WNL.57.11.2136","volume":"57","author":"E Gallardo","year":"2001","unstructured":"Gallardo E, Rojas-Garc\u00eda R, de Luna N, Pou A, Brown RH, Illa I. Inflammation in dysferlin myopathy: Immunohistochemical characterization of 13 patients. Neurology. 2001;57(11):2136\u20138.","journal-title":"Neurology"},{"issue":"3","key":"415_CR178","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1111\/ane.12109","volume":"128","author":"S Hauerslev","year":"2013","unstructured":"Hauerslev S, \u00d8rngreen MC, Hertz JM, Vissing J, Krag TO. Muscle regeneration and inflammation in patients with facioscapulohumeral muscular dystrophy. Acta Neurol Scand. 2013;128(3):194\u2013201.","journal-title":"Acta Neurol Scand"},{"issue":"2","key":"415_CR179","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1111\/brv.12674","volume":"96","author":"LL Ozimski","year":"2021","unstructured":"Ozimski LL, Sabater-Arcis M, Bargiela A, Artero R. The hallmarks of myotonic dystrophy type 1 muscle dysfunction. Biol Rev. 2021;96(2):716\u201330.","journal-title":"Biol Rev"},{"issue":"3","key":"415_CR180","doi-asserted-by":"publisher","first-page":"356","DOI":"10.4103\/0972-2327.186814","volume":"19","author":"K Konkay","year":"2016","unstructured":"Konkay K, Kannan MA, Lingappa L, Uppin MS, Challa S. Congenital muscular dystrophy with inflammation: diagnostic considerations. Ann Indian Acad Neurol. 2016;19(3):356\u20139.","journal-title":"Ann Indian Acad Neurol"},{"issue":"2","key":"415_CR181","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.phrs.2008.06.008","volume":"58","author":"S Brunelli","year":"2008","unstructured":"Brunelli S, Rovere-Querini P. The immune system and the repair of skeletal muscle. Pharmacol Res. 2008;58(2):117\u201321.","journal-title":"Pharmacol Res"},{"key":"415_CR182","unstructured":"Angelini C. Muscular dystrophy: Causes and management. 2013. p. 32\u201338."},{"issue":"1","key":"415_CR183","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1212\/WNL.50.1.41","volume":"50","author":"S Spuler","year":"1998","unstructured":"Spuler S, Engel AG. Unexpected sarcolemmal complement membrane attack complex deposits on nonnecrotic muscle fibers in muscular dystrophies. Neurology. 1998;50(1):41\u20136.","journal-title":"Neurology"},{"issue":"6","key":"415_CR184","doi-asserted-by":"publisher","first-page":"614","DOI":"10.4103\/0028-3886.125264","volume":"61","author":"M Nagappa","year":"2013","unstructured":"Nagappa M, Nalini A, Narayanappa G. Major histocompatibility complex and inflammatory cell subtype expression in inflammatory myopathies and muscular dystrophies. Neurol India. 2013;61(6):614.","journal-title":"Neurol India"},{"issue":"87","key":"415_CR185","doi-asserted-by":"publisher","first-page":"1809","DOI":"10.1590\/0001-3765201520140508","volume":"17","author":"CM Comim","year":"2015","unstructured":"Comim CM, Mathia GB, Hoepers A, Tuon L, Kapczinski F, Dal-Pizzol F, et al. Neurotrophins, cytokines, oxidative parameters and funcionality in Progressive Muscular Dystrophies. An Acad Bras Ci\u00eanc. 2015;17(87):1809\u201318.","journal-title":"An Acad Bras Ci\u00eanc"},{"issue":"2","key":"415_CR186","doi-asserted-by":"publisher","first-page":"327","DOI":"10.3233\/JND-230063","volume":"11","author":"A Greco","year":"2024","unstructured":"Greco A, Mul K, Jaeger MH, dos Santos JC, Koenen H, de Jong L, et al. IL-6 and TNF are potential inflammatory biomarkers in facioscapulohumeral muscular dystrophy. J Neuromuscul Dis. 2024;11(2):327\u201347.","journal-title":"J Neuromuscul Dis"},{"issue":"10","key":"415_CR187","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines9101366","volume":"9","author":"A Tulangekar","year":"2021","unstructured":"Tulangekar A, Sztal TE. Inflammation in duchenne muscular dystrophy\u2013exploring the role of neutrophils in muscle damage and regeneration. Biomedicines. 2021;9(10):1366.","journal-title":"Biomedicines"},{"issue":"5","key":"415_CR188","doi-asserted-by":"publisher","DOI":"10.3390\/jcm8050649","volume":"8","author":"L Bello","year":"2019","unstructured":"Bello L, Pegoraro E. The \u201cUsual Suspects\u201d: genes for inflammation, fibrosis, regeneration, and muscle strength modify Duchenne muscular dystrophy. J Clin Med. 2019;8(5):649.","journal-title":"J Clin Med"},{"issue":"8","key":"415_CR189","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1097\/NEN.0b013e3181e9a34b","volume":"69","author":"L Zhou","year":"2010","unstructured":"Zhou L, Lu H. Targeting fibrosis in Duchenne muscular dystrophy. J Neuropathol Exp Neurol. 2010;69(8):771\u20136.","journal-title":"J Neuropathol Exp Neurol"},{"issue":"13","key":"415_CR190","doi-asserted-by":"publisher","first-page":"3328","DOI":"10.3390\/ijms20133328","volume":"20","author":"N Kelley","year":"2019","unstructured":"Kelley N, Jeltema D, Duan Y, He Y. The NLRP3 inflammasome: an overview of mechanisms of activation and regulation. Int J Mol Sci. 2019;20(13):3328.","journal-title":"Int J Mol Sci"},{"key":"415_CR191","doi-asserted-by":"crossref","unstructured":"Liu Y, Wang D, Li T, Yang F, Li Z, Bai X, et al. The role of NLRP3 inflammasome in inflammation-related skeletal muscle atrophy. Front Immunol. 2022;13. Available from: https:\/\/www.frontiersin.org\/journals\/immunology\/articles\/10.3389\/fimmu.2022.1035709\/full. Cited 2024 June 11.","DOI":"10.3389\/fimmu.2022.1035709"},{"issue":"5","key":"415_CR192","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/s40635-016-0115-0","volume":"17","author":"N Huang","year":"2017","unstructured":"Huang N, Kny M, Riediger F, Busch K, Schmidt S, Luft FC, et al. Deletion of Nlrp3 protects from inflammation-induced skeletal muscle atrophy. Intensive Care Med Exp. 2017;17(5):3.","journal-title":"Intensive Care Med Exp"},{"issue":"1678","key":"415_CR193","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.brainres.2017.09.034","volume":"1","author":"H Yu","year":"2018","unstructured":"Yu H, Wu M, Lu G, Cao T, Chen N, Zhang Y, et al. Prednisone alleviates demyelination through regulation of the NLRP3 inflammasome in a C57BL\/6 mouse model of cuprizone-induced demyelination. Brain Res. 2018;1(1678):75\u201384.","journal-title":"Brain Res"},{"issue":"11","key":"415_CR194","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22116068","volume":"22","author":"C P\u00e9ladeau","year":"2021","unstructured":"P\u00e9ladeau C, Sandhu JK. Aberrant NLRP3 inflammasome activation ignites the fire of inflammation in neuromuscular diseases. Int J Mol Sci. 2021;22(11):6068.","journal-title":"Int J Mol Sci"},{"key":"415_CR195","doi-asserted-by":"publisher","unstructured":"Bandyopadhyay S, Lane T, Venugopal R, Parthasarathy PT, Cho Y, Galam L, et al. MicroRNA-133a-1 regulates inflammasome activation through uncoupling protein-2. Biochem Biophys Res Commun. 2013;439(3):https:\/\/doi.org\/10.1016\/j.bbrc.2013.08.056.","DOI":"10.1016\/j.bbrc.2013.08.056"},{"issue":"30","key":"415_CR196","doi-asserted-by":"publisher","first-page":"10212","DOI":"10.1074\/jbc.RA119.012263","volume":"295","author":"N Cheng","year":"2020","unstructured":"Cheng N, Liu C, Li Y, Gao S, Han YC, Wang X, et al. MicroRNA-223-3p promotes skeletal muscle regeneration by regulating inflammation in mice. J Biol Chem. 2020;295(30):10212\u201323.","journal-title":"J Biol Chem"},{"issue":"10","key":"415_CR197","first-page":"3335","volume":"23","author":"S Greco","year":"2009","unstructured":"Greco S, De Simone M, Colussi C, Zaccagnini G, Fasanaro P, Pescatori M, et al. Common micro-RNA signature in skeletal muscle damage and regeneration induced by Duchenne muscular dystrophy and acute ischemia. FASEB J Off Publ Fed Am Soc Exp Biol. 2009;23(10):3335\u201346.","journal-title":"FASEB J Off Publ Fed Am Soc Exp Biol"},{"issue":"1","key":"415_CR198","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/s13395-015-0051-9","volume":"5","author":"M Abou-Samra","year":"2015","unstructured":"Abou-Samra M, Lecompte S, Schakman O, Noel L, Many MC, Gailly P, et al. Involvement of adiponectin in the pathogenesis of dystrophinopathy. Skelet Muscle. 2015;5(1):25.","journal-title":"Skelet Muscle"},{"issue":"6","key":"415_CR199","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1530\/EJE-11-0537","volume":"165","author":"A Daniele","year":"2011","unstructured":"Daniele A, De Rosa A, De Cristofaro M, Monaco ML, Masullo M, Porcile C, et al. Decreased concentration of adiponectin together with a selective reduction of its high molecular weight oligomers is involved in metabolic complications of myotonic dystrophy type 1. Eur J Endocrinol. 2011;165(6):969\u201375.","journal-title":"Eur J Endocrinol"},{"key":"415_CR200","doi-asserted-by":"crossref","unstructured":"Grounds MD, Terrill JR, Al-Mshhdani BA, Duong MN, Radley-Crabb HG, Arthur PG. Biomarkers for Duchenne muscular dystrophy: myonecrosis, inflammation and oxidative stress. Dis Model Mech. 2020;13(2):dmm043638.","DOI":"10.1242\/dmm.043638"},{"issue":"9","key":"415_CR201","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1016\/j.nmd.2006.06.011","volume":"16","author":"S Hodgetts","year":"2006","unstructured":"Hodgetts S, Radley H, Davies M, Grounds MD. Reduced necrosis of dystrophic muscle by depletion of host neutrophils, or blocking TNF\u03b1 function with Etanercept in mdx mice. Neuromuscul Disord. 2006;16(9):591\u2013602.","journal-title":"Neuromuscul Disord"},{"issue":"7","key":"415_CR202","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.1002\/art.41215","volume":"72","author":"TB Kinder","year":"2020","unstructured":"Kinder TB, Heier CR, Tully CB, Van der Muelen JH, Hoffman EP, Nagaraju K, et al. Muscle weakness in myositis: microrna-mediated dystrophin reduction in a myositis mouse model and human muscle biopsies. Arthritis Rheumatol. 2020;72(7):1170\u201383.","journal-title":"Arthritis Rheumatol"},{"issue":"7","key":"415_CR203","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1111\/j.1440-1681.2007.04868.x","volume":"35","author":"MD Grounds","year":"2008","unstructured":"Grounds MD, Radley HG, Gebski BL, Bogoyevitch MA, Shavlakadze T. Implications of cross-talk between tumour necrosis factor and insulin-like growth factor-1 signalling in skeletal muscle. Clin Exp Pharmacol Physiol. 2008;35(7):846\u201351.","journal-title":"Clin Exp Pharmacol Physiol"},{"issue":"1","key":"415_CR204","volume":"2015","author":"OdelR Cruz-Guzm\u00e1n","year":"2015","unstructured":"Cruz-Guzm\u00e1n OdelR, Rodr\u00edguez-Cruz M, Escobar Cedillo RE. Systemic inflammation in Duchenne muscular dystrophy: association with muscle function and nutritional status. BioMed Res Int. 2015;2015(1):891972.","journal-title":"BioMed Res Int"},{"issue":"3","key":"415_CR205","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1007\/s00441-018-2955-2","volume":"375","author":"MAA Mahdy","year":"2019","unstructured":"Mahdy MAA. Skeletal muscle fibrosis: an overview. Cell Tissue Res. 2019;375(3):575\u201388.","journal-title":"Cell Tissue Res"},{"issue":"1","key":"415_CR206","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1016\/j.matbio.2018.01.014","volume":"68\u201369","author":"LR Smith","year":"2018","unstructured":"Smith LR, Barton ER. Regulation of fibrosis in muscular dystrophy. Matrix Biol. 2018;68\u201369(1):602\u201315.","journal-title":"Matrix Biol"},{"key":"415_CR207","doi-asserted-by":"crossref","unstructured":"Biferali B, Proietti D, Mozzetta C, Madaro L. Fibro\u2013adipogenic progenitors cross-talk in skeletal muscle: the social network. Front Physiol. 2019;10. Available from: https:\/\/www.frontiersin.org\/journals\/physiology\/articles\/10.3389\/fphys.2019.01074\/full. Cited 2024 June 5.","DOI":"10.3389\/fphys.2019.01074"},{"issue":"4","key":"415_CR208","volume":"2014","author":"Y Kharraz","year":"2014","unstructured":"Kharraz Y, Guerra J, Pessina P, Serrano AL, Mu\u00f1oz-C\u00e1noves P. Understanding the process of fibrosis in duchenne muscular dystrophy. BioMed Res Int. 2014;2014(4):e965631.","journal-title":"BioMed Res Int"},{"issue":"3","key":"415_CR209","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.tips.2014.01.003","volume":"35","author":"N Pottier","year":"2014","unstructured":"Pottier N, Cauffiez C, Perrais M, Barbry P, Mari B. Fibromirs: translating molecular discoveries into new anti-fibrotic drugs. Trends Pharmacol Sci. 2014;35(3):119\u201326.","journal-title":"Trends Pharmacol Sci"},{"issue":"10","key":"415_CR210","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1038\/nrm3434","volume":"13","author":"J Massagu\u00e9","year":"2012","unstructured":"Massagu\u00e9 J. Tgf\u03b2 signalling in context. Nat Rev Mol Cell Biol. 2012;13(10):616\u201330.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"3","key":"415_CR211","doi-asserted-by":"publisher","first-page":"1","DOI":"10.21926\/obm.genet.1902079","volume":"28","author":"B Paepe","year":"2019","unstructured":"Paepe B. The changed transcriptome of muscular dystrophy and inflammatory myopathy: contributions of non-coding RNAs to muscle damage and recovery. OBM Genet. 2019;28(3):1\u20131.","journal-title":"OBM Genet"},{"key":"415_CR212","doi-asserted-by":"crossref","unstructured":"Wei P, Xie Y, Abel PW, Huang Y, Ma Q, Li L, et al. Transforming growth factor (TGF)-\u03b21-induced miR-133a inhibits myofibroblast differentiation and pulmonary fibrosis. Cell Death Dis. 2019;10(9):670.","DOI":"10.1038\/s41419-019-1873-x"},{"issue":"1","key":"415_CR213","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1113\/JP280872","volume":"599","author":"E Rybalka","year":"2021","unstructured":"Rybalka E, Timpani CA. Micro (mRNA) molecules could pack a big punch in the fight against neuromuscular disease. J Physiol. 2021;599(1):5\u20136.","journal-title":"J Physiol"},{"issue":"1","key":"415_CR214","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1113\/JP280405","volume":"599","author":"T Taetzsch","year":"2021","unstructured":"Taetzsch T, Shapiro D, Eldosougi R, Myers T, Settlage RE, Valdez G. The microrna, mir-133b, functions to slow Duchenne muscular dystrophy pathogenesis. J Physiol. 2021;599(1):171\u201392.","journal-title":"J Physiol"},{"key":"415_CR215","doi-asserted-by":"crossref","unstructured":"Hamrick MW, McGee-Lawrence ME, Frechette DM. Fatty infiltration of skeletal muscle: mechanisms and comparisons with bone marrow adiposity. Front Endocrinol. 2016;7. Available from: https:\/\/www.frontiersin.org\/journals\/endocrinology\/articles\/10.3389\/fendo.2016.00069\/full. Cited 2024 June 5.","DOI":"10.3389\/fendo.2016.00069"},{"issue":"5","key":"415_CR216","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/j.nmd.2015.01.003","volume":"25","author":"W Li","year":"2015","unstructured":"Li W, Zheng Y, Zhang W, Wang Z, Xiao J, Yuan Y. Progression and variation of fatty infiltration of the thigh muscles in Duchenne muscular dystrophy, a muscle magnetic resonance imaging study. Neuromuscul Disord. 2015;25(5):375\u201380.","journal-title":"Neuromuscul Disord"},{"issue":"4","key":"415_CR217","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1002\/mus.22099","volume":"44","author":"L Pruna","year":"2011","unstructured":"Pruna L, Chatelin J, Pascal-Vigneron V, Kaminsky P. Regional body composition and functional impairment in patients with myotonic dystrophy. Muscle Nerve. 2011;44(4):503\u20138.","journal-title":"Muscle Nerve"},{"issue":"4","key":"415_CR218","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/j.nmd.2013.12.011","volume":"24","author":"CG B\u00f6nnemann","year":"2014","unstructured":"B\u00f6nnemann CG, Wang CH, Quijano-Roy S, Deconinck N, Bertini E, Ferreiro A, et al. Diagnostic approach to the congenital muscular dystrophies. Neuromuscul Disord. 2014;24(4):289\u2013311.","journal-title":"Neuromuscul Disord"},{"issue":"3","key":"415_CR219","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1002\/mus.20910","volume":"37","author":"P Seror","year":"2008","unstructured":"Seror P, Krahn M, Laforet P, Leturcq F, Maisonobe T. Complete fatty degeneration of lumbar erector spinae muscles caused by a primary dysferlinopathy. Muscle Nerve. 2008;37(3):410\u20134.","journal-title":"Muscle Nerve"},{"issue":"10","key":"415_CR220","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1016\/j.neurol.2016.08.002","volume":"172","author":"F Fatehi","year":"2016","unstructured":"Fatehi F, Salort-Campana E, Le Troter A, Bendahan D, Attarian S. Muscle MRI of facioscapulohumeral dystrophy (FSHD): A growing demand and a promising approach. Rev Neurol (Paris). 2016;172(10):566\u201371.","journal-title":"Rev Neurol (Paris)"},{"key":"415_CR221","doi-asserted-by":"crossref","unstructured":"Alonso-Jimenez A, Kroon RHMJM, Alejaldre-Monforte A, Nu\u00f1ez-Peralta C, Horlings CGC, Engelen BGM van, et al. Muscle MRI in a large cohort of patients with oculopharyngeal muscular dystrophy. J Neurol Neurosurg Psychiatry. 2019;90(5):576\u201385.","DOI":"10.1136\/jnnp-2018-319578"},{"issue":"21","key":"415_CR222","doi-asserted-by":"publisher","first-page":"3654","DOI":"10.1242\/jcs.086629","volume":"124","author":"A Uezumi","year":"2011","unstructured":"Uezumi A, Ito T, Morikawa D, Shimizu N, Yoneda T, Segawa M, et al. Fibrosis and adipogenesis originate from a common mesenchymal progenitor in skeletal muscle. J Cell Sci. 2011;124(21):3654\u201364.","journal-title":"J Cell Sci"},{"key":"415_CR223","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1016\/j.ebiom.2017.01.015","volume":"16","author":"C Wang","year":"2017","unstructured":"Wang C, Liu W, Nie Y, Qaher M, Horton HE, Yue F, et al. Loss of MyoD promotes fate transdifferentiation of myoblasts into brown adipocytes. EBioMedicine. 2017;16:212\u201323.","journal-title":"EBioMedicine"},{"issue":"Pt 23","key":"415_CR224","doi-asserted-by":"publisher","first-page":"5325","DOI":"10.1242\/jcs.114041","volume":"126","author":"M Sandri","year":"2013","unstructured":"Sandri M, Coletto L, Grumati P, Bonaldo P. Misregulation of autophagy and protein degradation systems in myopathies and muscular dystrophies. J Cell Sci. 2013;126(Pt 23):5325\u201333.","journal-title":"J Cell Sci"},{"issue":"10","key":"415_CR225","volume":"35","author":"\u00c1 Bl\u00e1zquez-Bernal","year":"2021","unstructured":"Bl\u00e1zquez-Bernal \u00c1, Fernandez-Costa JM, Bargiela A, Artero R. Inhibition of autophagy rescues muscle atrophy in a LGMDD2 Drosophila model. FASEB J Off Publ Fed Am Soc Exp Biol. 2021;35(10):e21914.","journal-title":"FASEB J Off Publ Fed Am Soc Exp Biol"},{"issue":"7","key":"415_CR226","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1242\/dmm.018127","volume":"8","author":"A Bargiela","year":"2015","unstructured":"Bargiela A, Cerro-Herreros E, Fernandez-Costa JM, Vilchez JJ, Llamusi B, Artero R. Increased autophagy and apoptosis contribute to muscle atrophy in a myotonic dystrophy type 1 Drosophila model. Dis Model Mech. 2015;8(7):679\u201390.","journal-title":"Dis Model Mech"},{"issue":"19","key":"415_CR227","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1016\/j.omtn.2019.11.012","volume":"6","author":"M Sabater-Arcis","year":"2020","unstructured":"Sabater-Arcis M, Bargiela A, Furling D, Artero R. miR-7 restores phenotypes in myotonic dystrophy muscle cells by repressing hyperactivated autophagy. Mol Ther - Nucleic Acids. 2020;6(19):278\u201392.","journal-title":"Mol Ther - Nucleic Acids"},{"issue":"7","key":"415_CR228","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41419-020-02756-8","volume":"11","author":"KY Song","year":"2020","unstructured":"Song KY, Guo XM, Wang HQ, Zhang L, Huang SY, Huo YC, et al. MBNL1 reverses the proliferation defect of skeletal muscle satellite cells in myotonic dystrophy type 1 by inhibiting autophagy via the mTOR pathway. Cell Death Dis. 2020;11(7):1\u201316.","journal-title":"Cell Death Dis"},{"key":"415_CR229","doi-asserted-by":"crossref","unstructured":"Sabater-Arcis M, Bargiela A, Moreno N, Poyatos-Garcia J, Vilchez JJ, Artero R. Musashi-2 contributes to myotonic dystrophy muscle dysfunction by promoting excessive autophagy through miR-7 biogenesis repression. Mol Ther Nucleic Acids. 2021;25:652\u201367.","DOI":"10.1016\/j.omtn.2021.08.010"},{"key":"415_CR230","doi-asserted-by":"crossref","unstructured":"Bargiela A, Sabater-Arcis M, Espinosa-Espinosa J, Zulaica M, Lopez de Munain A, Artero R. Increased Muscleblind levels by chloroquine treatment improve myotonic dystrophy type 1 phenotypes in in vitro and in vivo models. Proc Natl Acad Sci U S A. 2019;116(50):25203\u201313.","DOI":"10.1073\/pnas.1820297116"},{"issue":"5","key":"415_CR231","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1038\/8385","volume":"5","author":"S Baghdiguian","year":"1999","unstructured":"Baghdiguian S, Martin M, Richard I, Pons F, Astier C, Bourg N, et al. Calpain 3 deficiency is associated with myonuclear apoptosis and profound perturbation of the IkappaB alpha\/NF-kappaB pathway in limb-girdle muscular dystrophy type 2A. Nat Med. 1999;5(5):503\u201311.","journal-title":"Nat Med"},{"issue":"146","key":"415_CR232","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2019.104315","volume":"1","author":"Y Yu","year":"2019","unstructured":"Yu Y, Liu H, Yang D, He F, Yuan Y, Guo J, et al. Aloe-emodin attenuates myocardial infarction and apoptosis via up-regulating miR-133 expression. Pharmacol Res. 2019;1(146):104315.","journal-title":"Pharmacol Res"},{"issue":"R2","key":"415_CR233","doi-asserted-by":"publisher","first-page":"R116","DOI":"10.1093\/hmg\/ddr343","volume":"20","author":"G Sicot","year":"2011","unstructured":"Sicot G, Gourdon G, Gomes-Pereira M. Myotonic dystrophy, when simple repeats reveal complex pathogenic entities: new findings and future challenges. Hum Mol Genet. 2011;20(R2):R116\u201323.","journal-title":"Hum Mol Genet"},{"issue":"2","key":"415_CR234","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a006023","volume":"7","author":"IY Kuo","year":"2015","unstructured":"Kuo IY, Ehrlich BE. Signaling in muscle contraction. Cold Spring Harb Perspect Biol. 2015;7(2):a006023.","journal-title":"Cold Spring Harb Perspect Biol"},{"issue":"8","key":"415_CR235","doi-asserted-by":"publisher","first-page":"5370","DOI":"10.1074\/jbc.M806726200","volume":"284","author":"B Darbellay","year":"2009","unstructured":"Darbellay B, Arnaudeau S, K\u00f6nig S, Jousset H, Bader C, Demaurex N, et al. STIM1- and Orai1-dependent store-operated calcium entry regulates human myoblast differentiation. J Biol Chem. 2009;284(8):5370\u201380.","journal-title":"J Biol Chem"},{"issue":"16","key":"415_CR236","doi-asserted-by":"publisher","first-page":"2793","DOI":"10.1021\/bi3015983","volume":"52","author":"B Glancy","year":"2013","unstructured":"Glancy B, Willis WT, Chess DJ, Balaban RS. Effect of calcium on the oxidative phosphorylation cascade in skeletal muscle mitochondria. Biochemistry. 2013;52(16):2793\u2013809.","journal-title":"Biochemistry"},{"issue":"45","key":"415_CR237","doi-asserted-by":"publisher","first-page":"19023","DOI":"10.1073\/pnas.0906591106","volume":"106","author":"DP Millay","year":"2009","unstructured":"Millay DP, Goonasekera SA, Sargent MA, Maillet M, Aronow BJ, Molkentin JD. Calcium influx is sufficient to induce muscular dystrophy through a TRPC-dependent mechanism. Proc Natl Acad Sci. 2009;106(45):19023\u20138.","journal-title":"Proc Natl Acad Sci"},{"issue":"2","key":"415_CR238","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1139\/Y09-058","volume":"88","author":"DG Allen","year":"2010","unstructured":"Allen DG, Gervasio OL, Yeung EW, Whitehead NP. Calcium and the damage pathways in muscular dystrophy. Can J Physiol Pharmacol. 2010;88(2):83\u201391.","journal-title":"Can J Physiol Pharmacol"},{"key":"415_CR239","doi-asserted-by":"publisher","DOI":"10.1155\/2009\/340346","volume":"2009","author":"G Dayanithi","year":"2009","unstructured":"Dayanithi G, Richard I, Viero C, Mazuc E, Mallie S, Valmier J, et al. Alteration of sarcoplasmic reticulum Ca2+ release in skeletal muscle from calpain 3-deficient mice. Int J Cell Biol. 2009;2009:340346.","journal-title":"Int J Cell Biol"},{"issue":"4","key":"415_CR240","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1111\/nan.12076","volume":"40","author":"M Santoro","year":"2014","unstructured":"Santoro M, Piacentini R, Masciullo M, Bianchi MLE, Modoni A, Podda MV, et al. Alternative splicing alterations of Ca2+ handling genes are associated with Ca2+ signal dysregulation in myotonic dystrophy type 1 (DM1) and type 2 (DM2) myotubes. Neuropathol Appl Neurobiol. 2014;40(4):464\u201376.","journal-title":"Neuropathol Appl Neurobiol"},{"issue":"2","key":"415_CR241","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1096\/fj.201700182RRR","volume":"32","author":"RF Capogrosso","year":"2018","unstructured":"Capogrosso RF, Mantuano P, Uaesoontrachoon K, Cozzoli A, Giustino A, Dow T, et al. Ryanodine channel complex stabilizer compound S48168\/ARM210 as a disease modifier in dystrophin-deficient mdx mice: proof-of-concept study and independent validation of efficacy. FASEB J. 2018;32(2):1025\u201343.","journal-title":"FASEB J"},{"issue":"18","key":"415_CR242","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1016\/j.omtn.2019.09.020","volume":"6","author":"F Barth\u00e9l\u00e9my","year":"2019","unstructured":"Barth\u00e9l\u00e9my F, Wang RT, Hsu C, Douine ED, Marcantonio EE, Nelson SF, et al. Targeting RyR activity boosts antisense Exon 44 and 45 skipping in human DMD skeletal or cardiac muscle culture models. Mol Ther - Nucleic Acids. 2019;6(18):580\u20139.","journal-title":"Mol Ther - Nucleic Acids"},{"issue":"3","key":"415_CR243","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1016\/j.ymthe.2019.12.011","volume":"28","author":"NB Wasala","year":"2020","unstructured":"Wasala NB, Yue Y, Lostal W, Wasala LP, Niranjan N, Hajjar RJ, et al. Single SERCA2a therapy ameliorated dilated cardiomyopathy for 18 months in a mouse model of duchenne muscular dystrophy. Mol Ther. 2020;28(3):845\u201354.","journal-title":"Mol Ther"},{"issue":"7497","key":"415_CR244","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1038\/nature13073","volume":"508","author":"C Wahlquist","year":"2014","unstructured":"Wahlquist C, Jeong D, Rojas-Mu\u00f1oz A, Kho C, Lee A, Mitsuyama S, et al. Inhibition of miR-25 improves cardiac contractility in the failing heart. Nature. 2014;508(7497):531\u20135.","journal-title":"Nature"},{"issue":"170","key":"415_CR245","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.mad.2017.08.009","volume":"1","author":"BM Scicchitano","year":"2018","unstructured":"Scicchitano BM, Pelosi L, Sica G, Musar\u00f2 A. The physiopathologic role of oxidative stress in skeletal muscle. Mech Ageing Dev. 2018;1(170):37\u201344.","journal-title":"Mech Ageing Dev"},{"issue":"1","key":"415_CR246","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1007\/s10974-014-9380-2","volume":"35","author":"M Canton","year":"2014","unstructured":"Canton M, Menazza S, Di Lisa F. Oxidative stress in muscular dystrophy: from generic evidence to specific sources and targets. J Muscle Res Cell Motil. 2014;35(1):23\u201336.","journal-title":"J Muscle Res Cell Motil"},{"issue":"9","key":"415_CR247","doi-asserted-by":"publisher","first-page":"2161","DOI":"10.1113\/jphysiol.2011.207456","volume":"589","author":"JM Lawler","year":"2011","unstructured":"Lawler JM. Exacerbation of pathology by oxidative stress in respiratory and locomotor muscles with Duchenne muscular dystrophy. J Physiol. 2011;589(9):2161\u201370.","journal-title":"J Physiol"},{"issue":"4","key":"415_CR248","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1016\/S0960-8966(02)00284-5","volume":"13","author":"ST Winokur","year":"2003","unstructured":"Winokur ST, Barrett K, Martin JH, Forrester JR, Simon M, Tawil R, et al. Facioscapulohumeral muscular dystrophy (FSHD) myoblasts demonstrate increased susceptibility to oxidative stress. Neuromuscul Disord. 2003;13(4):322\u201333.","journal-title":"Neuromuscul Disord"},{"issue":"10","key":"415_CR249","doi-asserted-by":"publisher","first-page":"2009","DOI":"10.1007\/s11064-013-1107-z","volume":"38","author":"D Rajakumar","year":"2013","unstructured":"Rajakumar D, Alexander M, Oommen A. Oxidative stress, NF-\u03baB and the ubiquitin proteasomal pathway in the pathology of calpainopathy. Neurochem Res. 2013;38(10):2009\u201318.","journal-title":"Neurochem Res"},{"issue":"7","key":"415_CR250","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1080\/10715760500138932","volume":"39","author":"A Toscano","year":"2005","unstructured":"Toscano A, Messina S, Campo GM, Leo RD, Musumeci O, Rodolico C, et al. Oxidative stress in myotonic dystrophy type 1. Free Radic Res. 2005;39(7):771\u20136.","journal-title":"Free Radic Res"},{"issue":"2","key":"415_CR251","doi-asserted-by":"publisher","DOI":"10.3390\/jpm10020050","volume":"10","author":"N Vignier","year":"2020","unstructured":"Vignier N, Muchir A. An omics view of emery\u2013dreifuss muscular dystrophy. J Pers Med. 2020;10(2):50.","journal-title":"J Pers Med"},{"issue":"21","key":"415_CR252","doi-asserted-by":"publisher","first-page":"4207","DOI":"10.1093\/hmg\/ddq339","volume":"19","author":"S Menazza","year":"2010","unstructured":"Menazza S, Blaauw B, Tiepolo T, Toniolo L, Braghetta P, Spolaore B, et al. Oxidative stress by monoamine oxidases is causally involved in myofiber damage in muscular dystrophy. Hum Mol Genet. 2010;19(21):4207\u201315.","journal-title":"Hum Mol Genet"},{"issue":"1","key":"415_CR253","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1010015","volume":"18","author":"C Ribot","year":"2022","unstructured":"Ribot C, Soler C, Chartier A, Hayek SA, Na\u00eft-Sa\u00efdi R, Barbezier N, et al. Activation of the ubiquitin-proteasome system contributes to oculopharyngeal muscular dystrophy through muscle atrophy. PLOS Genet. 2022;18(1):e1010015.","journal-title":"PLOS Genet"},{"issue":"5","key":"415_CR254","doi-asserted-by":"publisher","DOI":"10.3390\/antiox7050062","volume":"7","author":"C Gaucher","year":"2018","unstructured":"Gaucher C, Boudier A, Bonetti J, Clarot I, Leroy P, Parent M. Glutathione: antioxidant properties dedicated to nanotechnologies. Antioxidants. 2018;7(5):62.","journal-title":"Antioxidants"},{"key":"415_CR255","doi-asserted-by":"crossref","unstructured":"Islam B ul, Habib S, Ahmad P, Allarakha S, Moinuddin, Ali A. Pathophysiological role of peroxynitrite induced DNA damage in human diseases: a special focus on poly(ADP-ribose) polymerase (PARP). Indian J Clin Biochem. 2015;30(4):368\u201385.","DOI":"10.1007\/s12291-014-0475-8"},{"issue":"5","key":"415_CR256","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1111\/ane.13673","volume":"146","author":"T Almeida-Becerril","year":"2022","unstructured":"Almeida-Becerril T, Rodr\u00edguez-Cruz M, Hern\u00e1ndez-Cruz SY, Ruiz-Cruz ED, Mendoza CRS, C\u00e1rdenas-Conejo A, et al. Natural history of circulating miRNAs in Duchenne disease: Association with muscle injury and metabolic parameters. Acta Neurol Scand. 2022;146(5):512\u201324.","journal-title":"Acta Neurol Scand"},{"issue":"2","key":"415_CR257","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1007\/s00109-009-0550-4","volume":"88","author":"S Bhatnagar","year":"2010","unstructured":"Bhatnagar S, Kumar A. Therapeutic targeting of signaling pathways in muscular dystrophy. J Mol Med. 2010;88(2):155\u201366.","journal-title":"J Mol Med"},{"issue":"1","key":"415_CR258","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1085\/jgp.201010436","volume":"136","author":"JA Goldstein","year":"2010","unstructured":"Goldstein JA, McNally EM. Mechanisms of muscle weakness in muscular dystrophy. J Gen Physiol. 2010;136(1):29\u201334.","journal-title":"J Gen Physiol"},{"key":"415_CR259","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-09688-y","volume":"24;7(1)","author":"L Hou","year":"2017","unstructured":"Hou L, Xu J, Li H, Ou J, Jiao Y, Hu C, et al. MiR-34c represses muscle development by forming a regulatory loop with Notch1. Sci Rep. 2017;24;7(1):9346.","journal-title":"Sci Rep"},{"issue":"3","key":"415_CR260","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1016\/j.bbrc.2016.09.117","volume":"479","author":"A Khayrullin","year":"2016","unstructured":"Khayrullin A, Smith L, Mistry D, Dukes A, Pan YA, Hamrick MW. Chronic alcohol exposure induces muscle atrophy (myopathy) in zebrafish and alters the expression of microRNAs targeting the Notch pathway in skeletal muscle. Biochem Biophys Res Commun. 2016;479(3):590\u20135.","journal-title":"Biochem Biophys Res Commun"},{"issue":"8","key":"415_CR261","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0012098","volume":"5","author":"VD Arcangelis","year":"2010","unstructured":"Arcangelis VD, Serra F, Cogoni C, Vivarelli E, Monaco L, Naro F. \u03b21-Syntrophin modulation by miR-222 in mdx Mice. PLoS ONE. 2010;5(8):e12098.","journal-title":"PLoS ONE"},{"issue":"1","key":"415_CR262","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1186\/s12964-019-0394-7","volume":"17","author":"S Poddar","year":"2019","unstructured":"Poddar S, Kesharwani D, Datta M. miR-449a regulates insulin signalling by targeting the Notch ligand, Jag1 in skeletal muscle cells. Cell Commun Signal CCS. 2019;17(1):84.","journal-title":"Cell Commun Signal CCS"},{"issue":"8","key":"415_CR263","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1161\/01.RES.0000126574.61061.25","volume":"94","author":"KA Lapidos","year":"2004","unstructured":"Lapidos KA, Kakkar R, McNally EM. The dystrophin glycoprotein complex: signaling strength and integrity for the sarcolemma. Circ Res. 2004;94(8):1023\u201331.","journal-title":"Circ Res"},{"issue":"12","key":"415_CR264","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1016\/j.nmd.2015.09.011","volume":"25","author":"JP Gonzalez","year":"2015","unstructured":"Gonzalez JP, Crassous PA, Schneider JS, Beuve A, Fraidenraich D. Neuronal nitric oxide synthase localizes to utrophin expressing intercalated discs and stabilizes their structural integrity. Neuromuscul Disord. 2015;25(12):964\u201376.","journal-title":"Neuromuscul Disord"},{"issue":"1","key":"415_CR265","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1242\/jcs.00183","volume":"116","author":"DS Bredt","year":"2003","unstructured":"Bredt DS. Nitric oxide signaling specificity\u2014the heart of the problem. J Cell Sci. 2003;116(1):9\u201315.","journal-title":"J Cell Sci"},{"issue":"3","key":"415_CR266","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1002\/jemt.1167","volume":"55","author":"Y Miyagoe-Suzuki","year":"2001","unstructured":"Miyagoe-Suzuki Y, Takeda S. Association of neuronal nitric oxide synthase (nNOS) with \u03b11-syntrophin at the sarcolemma. Microsc Res Tech. 2001;55(3):164\u201370.","journal-title":"Microsc Res Tech"},{"key":"415_CR267","doi-asserted-by":"crossref","unstructured":"Venema VJ, Ju H, Zou R, Venema RC. Interaction of neuronal nitric-oxide synthase with caveolin-3 in skeletal muscle. Identification of a novel caveolin scaffolding\/inhibitory domain. J Biol Chem. 1997;272(45):28187\u201390.","DOI":"10.1074\/jbc.272.45.28187"},{"issue":"11","key":"415_CR268","doi-asserted-by":"publisher","first-page":"1989","DOI":"10.1021\/bi501353s","volume":"54","author":"M Piazza","year":"2015","unstructured":"Piazza M, Guillemette JG, Dieckmann T. Dynamics of nitric oxide synthase-calmodulin interactions at physiological calcium concentrations. Biochemistry. 2015;54(11):1989\u20132000.","journal-title":"Biochemistry"},{"issue":"1","key":"415_CR269","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.yexcr.2016.04.001","volume":"344","author":"JA Lim","year":"2016","unstructured":"Lim JA, Choi SJ, Moon JY, Kim HS. \u03b1-Syntrophin is involved in the survival signaling pathway in myoblasts under menadione-induced oxidative stress. Exp Cell Res. 2016;344(1):1\u201310.","journal-title":"Exp Cell Res"},{"issue":"9","key":"415_CR270","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1212\/01.wnl.0000302174.08951.cf","volume":"70","author":"M Nakamori","year":"2008","unstructured":"Nakamori M, Kimura T, Kubota T, Matsumura T, Sumi H, Fujimura H, et al. Aberrantly spliced \u03b1-dystrobrevin alters \u03b1-syntrophin binding in myotonic dystrophy type 1. Neurology. 2008;70(9):677\u201385.","journal-title":"Neurology"},{"issue":"13","key":"415_CR271","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/1471-2121-13-26","volume":"29","author":"AK Marrone","year":"2012","unstructured":"Marrone AK, Edeleva EV, Kucherenko MM, Hsiao NH, Shcherbata HR. Dg-Dys-Syn1 signaling in Drosophila regulates the microRNA profile. BMC Cell Biol. 2012;29(13):26.","journal-title":"BMC Cell Biol"},{"issue":"7","key":"415_CR272","doi-asserted-by":"publisher","first-page":"4672","DOI":"10.1074\/jbc.M106879200","volume":"277","author":"PD C\u00f4t\u00e9","year":"2002","unstructured":"C\u00f4t\u00e9 PD, Moukhles H, Carbonetto S. Dystroglycan is not required for localization of dystrophin, syntrophin, and neuronal nitric-oxide synthase at the sarcolemma but regulates integrin \u03b17B expression and caveolin-3 distribution *. J Biol Chem. 2002;277(7):4672\u20139.","journal-title":"J Biol Chem"},{"issue":"1","key":"415_CR273","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/s13395-022-00293-w","volume":"12","author":"S Gioftsidi","year":"2022","unstructured":"Gioftsidi S, Relaix F, Mourikis P. The Notch signaling network in muscle stem cells during development, homeostasis, and disease. Skelet Muscle. 2022;12(1):9.","journal-title":"Skelet Muscle"},{"key":"415_CR274","doi-asserted-by":"crossref","unstructured":"Den Hartog L, Asakura A. Implications of notch signaling in duchenne muscular dystrophy. Front Physiol. 2022;13. Available from: https:\/\/www.frontiersin.org\/journals\/physiology\/articles\/fphys.2022.984373\/full. Cited 2024 May 25.","DOI":"10.3389\/fphys.2022.984373"},{"issue":"1","key":"415_CR275","doi-asserted-by":"publisher","first-page":"38174","DOI":"10.1038\/srep38174","volume":"6","author":"A Perfetti","year":"2016","unstructured":"Perfetti A, Greco S, Cardani R, Fossati B, Cuomo G, Valaperta R, et al. Validation of plasma microRNAs as biomarkers for myotonic dystrophy type 1. Sci Rep. 2016;6(1):38174.","journal-title":"Sci Rep"},{"issue":"48","key":"415_CR276","doi-asserted-by":"publisher","first-page":"40360","DOI":"10.1074\/jbc.M112.378414","volume":"287","author":"J Gagan","year":"2012","unstructured":"Gagan J, Dey BK, Layer R, Yan Z, Dutta A. Notch3 and Mef2c proteins are mutually antagonistic via Mkp1 protein and miR-1\/206 microRNAs in differentiating myoblasts *. J Biol Chem. 2012;287(48):40360\u201370.","journal-title":"J Biol Chem"},{"issue":"6","key":"415_CR277","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1002\/mus.21789","volume":"42","author":"LL Bachinski","year":"2010","unstructured":"Bachinski LL, Sirito M, B\u00f6hme M, Baggerly KA, Udd B, Krahe R. Altered MEF2 isoforms in myotonic dystrophy and other neuromuscular disorders. Muscle Nerve. 2010;42(6):856\u201363.","journal-title":"Muscle Nerve"},{"issue":"10","key":"415_CR278","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1007\/s00109-008-0373-8","volume":"86","author":"H Li","year":"2008","unstructured":"Li H, Malhotra S, Kumar A. Nuclear factor-kappa B signaling in skeletal muscle atrophy. J Mol Med (Berl). 2008;86(10):1113\u201326.","journal-title":"J Mol Med (Berl)"},{"key":"415_CR279","doi-asserted-by":"crossref","unstructured":"Baeuerle PA, Henkel T. Function and activation of NF-kappaB in the immune system. Annu Rev Immunol. 1994;12(1994):141\u201379.","DOI":"10.1146\/annurev.iy.12.040194.001041"},{"key":"415_CR280","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1093\/hmg\/11.3.263","volume":"1;11(3)","author":"JD Porter","year":"2002","unstructured":"Porter JD, Khanna S, Kaminski HJ, Rao JS, Merriam AP, Richmonds CR. A chronic inflammatory response dominates the skeletal muscle molecular signature in dystrophin-deficient mdx mice. Hum Mol Genet. 2002;1;11(3):263\u201372.","journal-title":"Hum Mol Genet"},{"issue":"2","key":"415_CR281","doi-asserted-by":"publisher","first-page":"R345","DOI":"10.1152\/ajpregu.00454.2004","volume":"288","author":"JG Tidball","year":"2005","unstructured":"Tidball JG. Inflammatory processes in muscle injury and repair. Am J Physiol Regul Integr Comp Physiol. 2005;288(2):R345-353.","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"415_CR282","doi-asserted-by":"publisher","first-page":"2308","DOI":"10.7150\/ijbs.59876","volume":"4;17(9)","author":"P Jiao","year":"2021","unstructured":"Jiao P, Wang XP, Luoreng ZM, Yang J, Jia L, Ma Y, et al. MiR-223: an effective regulator of immune cell differentiation and inflammation. Int J Biol Sci. 2021;4;17(9):2308\u201322.","journal-title":"Int J Biol Sci"},{"key":"415_CR283","first-page":"670","volume":"15;7(4)","author":"CG Carlson","year":"2015","unstructured":"Carlson CG, Dole E, Stefanski C, Bayless D. The effect of specific IKK\u03b2 inhibitors on the cytosolic expression of I\u03baB-\u03b1 and the nuclear expression of p65 in dystrophic (MDX) muscle. Am J Transl Res. 2015;15;7(4):670\u201382.","journal-title":"Am J Transl Res"},{"issue":"9","key":"415_CR284","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1038\/ni.1918","volume":"11","author":"T Li","year":"2010","unstructured":"Li T, Morgan MJ, Choksi S, Zhang Y, Kim YS, Liu Z. MicroRNAs modulate the noncanonical transcription factor NF-\u03baB pathway by regulating expression of the kinase IKK\u03b1 during macrophage differentiation. Nat Immunol. 2010;11(9):799\u2013805.","journal-title":"Nat Immunol"},{"issue":"3","key":"415_CR285","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1002\/mus.24167","volume":"50","author":"M Fanin","year":"2014","unstructured":"Fanin M, Nascimbeni AC, Angelini C. Muscle atrophy, ubiquitin\u2013proteasome, and autophagic pathways in dysferlinopathy. Muscle Nerve. 2014;50(3):340\u20137.","journal-title":"Muscle Nerve"},{"issue":"13","key":"415_CR286","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.843202","volume":"7","author":"M Li","year":"2022","unstructured":"Li M, Xu F, Liu Z, Wang C, Zhao Y, Zhu G, et al. TNF signaling acts downstream of MiR-322\/-503 in regulating DM1 myogenesis. Front Endocrinol. 2022;7(13):843202.","journal-title":"Front Endocrinol"},{"key":"415_CR287","doi-asserted-by":"crossref","unstructured":"Fiorillo AA, Tully CB, Damsker JM, Nagaraju K, Hoffman EP, Heier CR. Muscle miRNAome shows suppression of chronic inflammatory miRNAs with both prednisone and vamorolone. Physiol Genomics. 2018;50(9):735\u201345.","DOI":"10.1152\/physiolgenomics.00134.2017"},{"issue":"8","key":"415_CR288","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0043464","volume":"7","author":"S Maciotta","year":"2012","unstructured":"Maciotta S, Meregalli M, Cassinelli L, Parolini D, Farini A, Fraro GD, et al. Hmgb3 is regulated by microRNA-206 during muscle regeneration. PLoS ONE. 2012;7(8):e43464.","journal-title":"PLoS ONE"},{"key":"415_CR289","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0150501","volume":"26;11(2)","author":"JM Fernandez-Costa","year":"2016","unstructured":"Fernandez-Costa JM, Llamusi B, Bargiela A, Zulaica M, Alvarez-Abril MC, Perez-Alonso M, et al. Six serum mirnas fail to validate as myotonic dystrophy type 1 biomarkers. PLoS ONE. 2016;26;11(2):e0150501.","journal-title":"PLoS ONE"}],"container-title":["Inflammation and Regeneration"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s41232-026-00415-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s41232-026-00415-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s41232-026-00415-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T09:02:55Z","timestamp":1776070975000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s41232-026-00415-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,11]]},"references-count":289,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["415"],"URL":"https:\/\/doi.org\/10.1186\/s41232-026-00415-7","relation":{},"ISSN":["1880-8190"],"issn-type":[{"value":"1880-8190","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,11]]},"assertion":[{"value":"4 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"15"}}